In the last 12 months, insiders at MADRIGAL PHARMACEUTICALS, INC. ($MDGL) filed 669 transactions with the SEC: 56 open-market purchases totaling $61,921,544 and 402 sales totaling $284,071,607. Net insider sentiment: net selling.
MADRIGAL PHARMACEUTICALS, INC. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- FRIEDMAN PAUL A (Director) — 123 transactions totaling $123,217,238
- BAKER BROS. ADVISORS LP (Not found) — 64 transactions totaling $61,921,544
- Taub Rebecca (Director) — 81 transactions totaling $50,125,991
- BATE KENNETH (Director) — 67 transactions totaling $34,323,386
- Taub Rebecca (Pres., R&D, and CMO) — 41 transactions totaling $20,460,501
View all SEC Filings for MADRIGAL PHARMACEUTICALS, INC. (MDGL).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 4, 2026 | Soergel David | Chief Medical Officer | A | Common Stock | 4374 | $0.00 | 11,919.0000 | 22,939,969 | 57.97% | 0.02% |
| March 6, 2026 | Dier Mardi | EVP and CFO | S | Common Stock | 80 | $436.69 | 12,530.0000 | 22,939,969 | 0.63% | 0.00% |
| March 6, 2026 | Dier Mardi | EVP and CFO | S | Common Stock | 40 | $437.65 | 12,490.0000 | 22,939,969 | 0.32% | 0.00% |
| March 4, 2026 | Dier Mardi | EVP and CFO | A | Stock Option (Right to Buy) | 6519 | $0.00 | 6,519.0000 | 22,939,969 | 9999.99% | 0.03% |
| March 4, 2026 | Sibold William John | President and CEO | A | Common Stock | 14995 | $0.00 | 163,492.0000 | 22,939,969 | 10.10% | 0.07% |
| March 6, 2026 | Sibold William John | President and CEO | S | Common Stock | 1663 | $431.94 | 161,829.0000 | 22,939,969 | 1.02% | 0.01% |
| March 4, 2026 | Sibold William John | President and CEO | A | Stock Option (Right to Buy) | 18743 | $0.00 | 18,743.0000 | 22,939,969 | 9999.99% | 0.08% |
| March 4, 2026 | Kelley Shannon T | General Counsel | A | Common Stock | 4017 | $0.00 | 12,498.0000 | 22,939,969 | 47.36% | 0.02% |
| March 6, 2026 | Kelley Shannon T | General Counsel | S | Common Stock | 360 | $431.94 | 12,138.0000 | 22,939,969 | 2.88% | 0.00% |
| March 4, 2026 | Kelley Shannon T | General Counsel | A | Stock Option (Right to Buy) | 5022 | $0.00 | 5,022.0000 | 22,939,969 | 9999.99% | 0.02% |
| March 4, 2026 | Huntsman Carole | Chief Commercial Officer | A | Common Stock | 3989 | $0.00 | 13,111.0000 | 22,939,969 | 43.73% | 0.02% |
| March 6, 2026 | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 419 | $431.94 | 12,692.0000 | 22,939,969 | 3.20% | 0.00% |
| March 4, 2026 | Huntsman Carole | Chief Commercial Officer | A | Stock Option (Right to Buy) | 4986 | $0.00 | 4,986.0000 | 22,939,969 | 9999.99% | 0.02% |
| March 6, 2026 | Taub Rebecca | Director | S | Common Stock | 491 | $431.94 | 1,107,753.0000 | 22,939,969 | 0.04% | 0.00% |
| March 4, 2026 | Soergel David | Chief Medical Officer | A | Stock Option (Right to Buy) | 5467 | $0.00 | 5,467.0000 | 22,939,969 | 9999.99% | 0.02% |
| March 4, 2026 | Dier Mardi | EVP and CFO | A | Common Stock | 5215 | $0.00 | 14,472.0000 | 22,939,969 | 56.34% | 0.02% |
| March 6, 2026 | Dier Mardi | EVP and CFO | S | Common Stock | 646 | $431.94 | 13,826.0000 | 22,939,969 | 4.46% | 0.00% |
| March 6, 2026 | Dier Mardi | EVP and CFO | S | Common Stock | 40 | $425.08 | 13,786.0000 | 22,939,969 | 0.29% | 0.00% |
| March 6, 2026 | Dier Mardi | EVP and CFO | S | Common Stock | 420 | $426.86 | 13,366.0000 | 22,939,969 | 3.05% | 0.00% |
| March 6, 2026 | Dier Mardi | EVP and CFO | S | Common Stock | 80 | $427.85 | 13,286.0000 | 22,939,969 | 0.60% | 0.00% |
| March 6, 2026 | Dier Mardi | EVP and CFO | S | Common Stock | 160 | $429.00 | 13,126.0000 | 22,939,969 | 1.20% | 0.00% |
| March 6, 2026 | Dier Mardi | EVP and CFO | S | Common Stock | 40 | $429.58 | 13,086.0000 | 22,939,969 | 0.30% | 0.00% |
| March 6, 2026 | Dier Mardi | EVP and CFO | S | Common Stock | 120 | $430.90 | 12,966.0000 | 22,939,969 | 0.92% | 0.00% |
| March 6, 2026 | Dier Mardi | EVP and CFO | S | Common Stock | 116 | $432.56 | 12,850.0000 | 22,939,969 | 0.89% | 0.00% |
| March 6, 2026 | Dier Mardi | EVP and CFO | S | Common Stock | 160 | $434.20 | 12,690.0000 | 22,939,969 | 1.25% | 0.00% |
| March 6, 2026 | Dier Mardi | EVP and CFO | S | Common Stock | 80 | $435.32 | 12,610.0000 | 22,939,969 | 0.63% | 0.00% |
| March 2, 2026 | Dier Mardi | EVP and CFO | S | Common Stock | 1183 | $427.21 | 9,257.0000 | 22,939,969 | 11.33% | 0.01% |
| Feb. 23, 2026 | Levy Richard S | Director | M | Common Stock | 2500 | $7.36 | 27,697.0000 | 22,939,969 | 9.92% | 0.01% |
| Feb. 23, 2026 | Levy Richard S | Director | M | Stock Option (Right to Buy) | 2500 | $0.00 | 0.0000 | 22,939,969 | 100.00% | 0.01% |
| Jan. 26, 2026 | Sibold William John | President and CEO | S | Common Stock | 1577 | $492.42 | 148,497.0000 | 22,711,420 | 1.05% | 0.01% |
| Jan. 26, 2026 | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 340 | $492.42 | 9,692.0000 | 22,711,420 | 3.39% | 0.00% |
| Jan. 26, 2026 | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 570 | $494.59 | 9,122.0000 | 22,711,420 | 5.88% | 0.00% |
| Jan. 26, 2026 | Taub Rebecca | Director | S | Common Stock | 647 | $492.42 | 1,108,244.0000 | 22,711,420 | 0.06% | 0.00% |
| Jan. 26, 2026 | Levy Richard S | Director | M | Common Stock | 4000 | $16.46 | 25,197.0000 | 22,711,420 | 18.87% | 0.02% |
| Jan. 26, 2026 | Levy Richard S | Director | M | Stock Option (Right to Buy) | 4000 | $0.00 | 0.0000 | 22,711,420 | 100.00% | 0.02% |
| Jan. 20, 2026 | Kelley Shannon T | General Counsel | S | Common Stock | 429 | $501.40 | 8,481.0000 | 22,711,420 | 4.81% | 0.00% |
| Jan. 15, 2026 | Thakkar Rita | Chief Accounting Officer | A | Stock Option (Right to Buy) | 1826 | $0.00 | 1,826.0000 | 22,711,420 | 9999.99% | 0.01% |
| Jan. 15, 2026 | Thakkar Rita | Chief Accounting Officer | A | Common Stock | 2398 | $0.00 | 2,398.0000 | 22,711,420 | 9999.99% | 0.01% |
| Jan. 20, 2026 | Taub Rebecca | Director | S | Common Stock | 2238 | $490.77 | 1,108,891.0000 | 22,711,420 | 0.20% | 0.01% |
| Jan. 20, 2026 | Kelley Shannon T | General Counsel | S | Common Stock | 263 | $490.77 | 8,910.0000 | 22,711,420 | 2.87% | 0.00% |
| Jan. 9, 2026 | Taub Rebecca | Director | S | Common Stock | 960 | $513.12 | 1,127,619.0000 | 22,711,420 | 0.09% | 0.00% |
| Jan. 9, 2026 | Taub Rebecca | Director | S | Common Stock | 937 | $514.63 | 1,126,682.0000 | 22,711,420 | 0.08% | 0.00% |
| Jan. 9, 2026 | Taub Rebecca | Director | S | Common Stock | 1578 | $515.82 | 1,125,104.0000 | 22,711,420 | 0.14% | 0.01% |
| Jan. 9, 2026 | Taub Rebecca | Director | S | Common Stock | 521 | $516.81 | 1,124,583.0000 | 22,711,420 | 0.05% | 0.00% |
| Jan. 9, 2026 | Taub Rebecca | Director | S | Common Stock | 2044 | $517.84 | 1,122,539.0000 | 22,711,420 | 0.18% | 0.01% |
| Jan. 9, 2026 | Taub Rebecca | Director | S | Common Stock | 970 | $518.67 | 1,121,569.0000 | 22,711,420 | 0.09% | 0.00% |
| Jan. 9, 2026 | Taub Rebecca | Director | S | Common Stock | 539 | $519.89 | 1,121,030.0000 | 22,711,420 | 0.05% | 0.00% |
| Jan. 9, 2026 | Taub Rebecca | Director | S | Common Stock | 440 | $521.11 | 1,120,590.0000 | 22,711,420 | 0.04% | 0.00% |
| Jan. 9, 2026 | Taub Rebecca | Director | S | Common Stock | 588 | $521.95 | 1,120,002.0000 | 22,711,420 | 0.05% | 0.00% |
| Jan. 9, 2026 | Taub Rebecca | Director | S | Common Stock | 732 | $522.98 | 1,119,270.0000 | 22,711,420 | 0.07% | 0.00% |
| Jan. 9, 2026 | Taub Rebecca | Director | S | Common Stock | 1335 | $524.06 | 1,117,935.0000 | 22,711,420 | 0.12% | 0.01% |
| Jan. 9, 2026 | Taub Rebecca | Director | S | Common Stock | 1489 | $525.12 | 1,116,446.0000 | 22,711,420 | 0.13% | 0.01% |
| Jan. 9, 2026 | Taub Rebecca | Director | S | Common Stock | 913 | $526.05 | 1,115,533.0000 | 22,711,420 | 0.08% | 0.00% |
| Jan. 9, 2026 | Taub Rebecca | Director | S | Common Stock | 1135 | $526.95 | 1,114,398.0000 | 22,711,420 | 0.10% | 0.00% |
| Jan. 9, 2026 | Taub Rebecca | Director | S | Common Stock | 465 | $528.16 | 1,113,933.0000 | 22,711,420 | 0.04% | 0.00% |
| Jan. 9, 2026 | Taub Rebecca | Director | S | Common Stock | 554 | $529.28 | 1,113,379.0000 | 22,711,420 | 0.05% | 0.00% |
| Jan. 9, 2026 | Taub Rebecca | Director | S | Common Stock | 256 | $530.45 | 1,113,123.0000 | 22,711,420 | 0.02% | 0.00% |
| Jan. 9, 2026 | Taub Rebecca | Director | S | Common Stock | 30 | $531.05 | 1,113,093.0000 | 22,711,420 | 0.00% | 0.00% |
| Jan. 9, 2026 | Taub Rebecca | Director | S | Common Stock | 40 | $532.50 | 1,113,053.0000 | 22,711,420 | 0.00% | 0.00% |
| Jan. 9, 2026 | Taub Rebecca | Director | S | Common Stock | 271 | $534.18 | 1,112,782.0000 | 22,711,420 | 0.02% | 0.00% |
| Jan. 9, 2026 | Taub Rebecca | Director | S | Common Stock | 89 | $534.93 | 1,112,693.0000 | 22,711,420 | 0.01% | 0.00% |
| Jan. 9, 2026 | Taub Rebecca | Director | S | Common Stock | 299 | $535.80 | 1,112,394.0000 | 22,711,420 | 0.03% | 0.00% |
| Jan. 9, 2026 | Taub Rebecca | Director | S | Common Stock | 385 | $536.88 | 1,112,009.0000 | 22,711,420 | 0.03% | 0.00% |
| Jan. 9, 2026 | Taub Rebecca | Director | S | Common Stock | 40 | $537.84 | 1,111,969.0000 | 22,711,420 | 0.00% | 0.00% |
| Jan. 9, 2026 | Taub Rebecca | Director | S | Common Stock | 400 | $539.26 | 1,111,569.0000 | 22,711,420 | 0.04% | 0.00% |
| Jan. 9, 2026 | Taub Rebecca | Director | S | Common Stock | 40 | $540.26 | 1,111,529.0000 | 22,711,420 | 0.00% | 0.00% |
| Jan. 9, 2026 | Taub Rebecca | Director | M | Stock Option (Right to Buy) | 18410 | $0.00 | 240.0000 | 22,711,420 | 98.71% | 0.08% |
| Jan. 9, 2026 | Taub Rebecca | Director | S | Common Stock | 400 | $542.72 | 1,111,129.0000 | 22,711,420 | 0.04% | 0.00% |
| Jan. 9, 2026 | FRIEDMAN PAUL A | Director | M | Common Stock | 280 | $15.80 | 842,984.0000 | 22,711,420 | 0.03% | 0.00% |
| Jan. 9, 2026 | FRIEDMAN PAUL A | Director | S | Common Stock | 280 | $551.24 | 842,704.0000 | 22,711,420 | 0.03% | 0.00% |
| Jan. 9, 2026 | FRIEDMAN PAUL A | Director | M | Stock Option (Right to Buy) | 280 | $0.00 | 0.0000 | 22,711,420 | 100.00% | 0.00% |
| Jan. 9, 2026 | FRIEDMAN PAUL A | Director | M | Common Stock | 24520 | $15.80 | 867,224.0000 | 22,711,420 | 2.91% | 0.11% |
| Jan. 9, 2026 | FRIEDMAN PAUL A | Director | S | Common Stock | 1480 | $511.98 | 865,744.0000 | 22,711,420 | 0.17% | 0.01% |
| Jan. 9, 2026 | FRIEDMAN PAUL A | Director | S | Common Stock | 1094 | $513.11 | 864,650.0000 | 22,711,420 | 0.13% | 0.00% |
| Jan. 9, 2026 | FRIEDMAN PAUL A | Director | S | Common Stock | 1345 | $514.68 | 863,305.0000 | 22,711,420 | 0.16% | 0.01% |
| Jan. 9, 2026 | FRIEDMAN PAUL A | Director | S | Common Stock | 1996 | $515.81 | 861,309.0000 | 22,711,420 | 0.23% | 0.01% |
| Jan. 9, 2026 | FRIEDMAN PAUL A | Director | S | Common Stock | 766 | $516.84 | 860,543.0000 | 22,711,420 | 0.09% | 0.00% |
| Jan. 9, 2026 | FRIEDMAN PAUL A | Director | S | Common Stock | 2450 | $517.86 | 858,093.0000 | 22,711,420 | 0.28% | 0.01% |
| Jan. 9, 2026 | FRIEDMAN PAUL A | Director | S | Common Stock | 1363 | $518.68 | 856,730.0000 | 22,711,420 | 0.16% | 0.01% |
| Jan. 9, 2026 | FRIEDMAN PAUL A | Director | S | Common Stock | 846 | $519.88 | 855,884.0000 | 22,711,420 | 0.10% | 0.00% |
| Jan. 9, 2026 | FRIEDMAN PAUL A | Director | S | Common Stock | 681 | $521.03 | 855,203.0000 | 22,711,420 | 0.08% | 0.00% |
| Jan. 9, 2026 | FRIEDMAN PAUL A | Director | S | Common Stock | 840 | $521.98 | 854,363.0000 | 22,711,420 | 0.10% | 0.00% |
| Jan. 9, 2026 | FRIEDMAN PAUL A | Director | S | Common Stock | 970 | $523.00 | 853,393.0000 | 22,711,420 | 0.11% | 0.00% |
| Jan. 9, 2026 | FRIEDMAN PAUL A | Director | S | Common Stock | 1199 | $524.10 | 852,194.0000 | 22,711,420 | 0.14% | 0.01% |
| Jan. 9, 2026 | FRIEDMAN PAUL A | Director | S | Common Stock | 2432 | $525.05 | 849,762.0000 | 22,711,420 | 0.29% | 0.01% |
| Jan. 9, 2026 | FRIEDMAN PAUL A | Director | S | Common Stock | 1066 | $526.00 | 848,696.0000 | 22,711,420 | 0.13% | 0.00% |
| Jan. 9, 2026 | FRIEDMAN PAUL A | Director | S | Common Stock | 1560 | $526.97 | 847,136.0000 | 22,711,420 | 0.18% | 0.01% |
| Jan. 9, 2026 | FRIEDMAN PAUL A | Director | S | Common Stock | 575 | $528.18 | 846,561.0000 | 22,711,420 | 0.07% | 0.00% |
| Jan. 9, 2026 | FRIEDMAN PAUL A | Director | S | Common Stock | 691 | $529.17 | 845,870.0000 | 22,711,420 | 0.08% | 0.00% |
| Jan. 9, 2026 | FRIEDMAN PAUL A | Director | S | Common Stock | 166 | $529.76 | 845,704.0000 | 22,711,420 | 0.02% | 0.00% |
| Jan. 9, 2026 | FRIEDMAN PAUL A | Director | S | Common Stock | 280 | $530.69 | 845,424.0000 | 22,711,420 | 0.03% | 0.00% |
| Jan. 9, 2026 | FRIEDMAN PAUL A | Director | S | Common Stock | 80 | $532.50 | 845,344.0000 | 22,711,420 | 0.01% | 0.00% |
| Jan. 9, 2026 | FRIEDMAN PAUL A | Director | S | Common Stock | 332 | $534.16 | 845,012.0000 | 22,711,420 | 0.04% | 0.00% |
| Jan. 9, 2026 | FRIEDMAN PAUL A | Director | S | Common Stock | 148 | $535.29 | 844,864.0000 | 22,711,420 | 0.02% | 0.00% |
| Jan. 9, 2026 | FRIEDMAN PAUL A | Director | S | Common Stock | 473 | $536.02 | 844,391.0000 | 22,711,420 | 0.06% | 0.00% |
| Jan. 9, 2026 | FRIEDMAN PAUL A | Director | S | Common Stock | 487 | $536.88 | 843,904.0000 | 22,711,420 | 0.06% | 0.00% |
| Jan. 9, 2026 | FRIEDMAN PAUL A | Director | S | Common Stock | 80 | $537.85 | 843,824.0000 | 22,711,420 | 0.01% | 0.00% |
| Jan. 9, 2026 | FRIEDMAN PAUL A | Director | S | Common Stock | 480 | $539.23 | 843,344.0000 | 22,711,420 | 0.06% | 0.00% |
| Jan. 9, 2026 | FRIEDMAN PAUL A | Director | S | Common Stock | 600 | $540.36 | 842,744.0000 | 22,711,420 | 0.07% | 0.00% |
| Jan. 9, 2026 | FRIEDMAN PAUL A | Director | S | Common Stock | 40 | $545.79 | 842,704.0000 | 22,711,420 | 0.00% | 0.00% |
| Jan. 9, 2026 | FRIEDMAN PAUL A | Director | M | Stock Option (Right to Buy) | 24520 | $0.00 | 280.0000 | 22,711,420 | 98.87% | 0.11% |
| Jan. 9, 2026 | Taub Rebecca | Director | M | Common Stock | 240 | $15.80 | 1,111,369.0000 | 22,711,420 | 0.02% | 0.00% |
| Jan. 9, 2026 | Taub Rebecca | Director | S | Common Stock | 40 | $545.79 | 1,111,329.0000 | 22,711,420 | 0.00% | 0.00% |
| Jan. 9, 2026 | Taub Rebecca | Director | S | Common Stock | 200 | $551.24 | 1,111,129.0000 | 22,711,420 | 0.02% | 0.00% |
| Jan. 9, 2026 | Taub Rebecca | Director | M | Stock Option (Right to Buy) | 240 | $0.00 | 0.0000 | 22,711,420 | 100.00% | 0.00% |
| Jan. 9, 2026 | Taub Rebecca | Director | M | Common Stock | 18410 | $15.80 | 1,129,539.0000 | 22,711,420 | 1.66% | 0.08% |
| Jan. 9, 2026 | Taub Rebecca | Director | S | Common Stock | 960 | $512.02 | 1,128,579.0000 | 22,711,420 | 0.08% | 0.00% |
| Dec. 10, 2025 | Taub Rebecca | Director | S | Common Stock | 3857 | $552.81 | 1,120,898.0000 | 22,711,420 | 0.34% | 0.02% |
| Dec. 10, 2025 | Taub Rebecca | Director | M | Stock Option (Right to Buy) | 18650 | $0.00 | 18,650.0000 | 22,711,420 | 50.00% | 0.08% |
| Dec. 10, 2025 | Taub Rebecca | Director | G | Common Stock | 5455 | $0.00 | 1,111,129.0000 | 22,711,420 | 0.49% | 0.02% |
| Dec. 10, 2025 | Taub Rebecca | Director | S | Common Stock | 200 | $555.39 | 1,116,584.0000 | 22,711,420 | 0.02% | 0.00% |
| Dec. 10, 2025 | Taub Rebecca | Director | S | Common Stock | 1027 | $554.84 | 1,116,784.0000 | 22,711,420 | 0.09% | 0.00% |
| Dec. 10, 2025 | Taub Rebecca | Director | S | Common Stock | 3087 | $553.88 | 1,117,811.0000 | 22,711,420 | 0.28% | 0.01% |
| Dec. 10, 2025 | Taub Rebecca | Director | S | Common Stock | 4410 | $551.85 | 1,124,755.0000 | 22,711,420 | 0.39% | 0.02% |
| Dec. 10, 2025 | Taub Rebecca | Director | S | Common Stock | 4723 | $550.99 | 1,129,165.0000 | 22,711,420 | 0.42% | 0.02% |
| Dec. 10, 2025 | Taub Rebecca | Director | S | Common Stock | 486 | $550.07 | 1,133,888.0000 | 22,711,420 | 0.04% | 0.00% |
| Dec. 10, 2025 | Taub Rebecca | Director | S | Common Stock | 369 | $548.56 | 1,134,374.0000 | 22,711,420 | 0.03% | 0.00% |
| Dec. 10, 2025 | Taub Rebecca | Director | S | Common Stock | 491 | $547.76 | 1,134,743.0000 | 22,711,420 | 0.04% | 0.00% |
| Dec. 10, 2025 | Taub Rebecca | Director | M | Common Stock | 18650 | $15.80 | 1,135,234.0000 | 22,711,420 | 1.67% | 0.08% |
| Dec. 10, 2025 | FRIEDMAN PAUL A | Director | M | Stock Option (Right to Buy) | 24800 | $0.00 | 24,800.0000 | 22,711,420 | 50.00% | 0.11% |
| Dec. 10, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 160 | $555.39 | 842,704.0000 | 22,711,420 | 0.02% | 0.00% |
| Dec. 10, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 1029 | $555.00 | 842,864.0000 | 22,711,420 | 0.12% | 0.00% |
| Dec. 10, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 5001 | $553.83 | 843,893.0000 | 22,711,420 | 0.59% | 0.02% |
| Dec. 10, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 5533 | $552.74 | 848,894.0000 | 22,711,420 | 0.65% | 0.02% |
| Dec. 10, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 7193 | $551.67 | 854,427.0000 | 22,711,420 | 0.83% | 0.03% |
| Dec. 10, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 4316 | $550.93 | 861,620.0000 | 22,711,420 | 0.50% | 0.02% |
| Dec. 10, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 409 | $549.99 | 865,936.0000 | 22,711,420 | 0.05% | 0.00% |
| Dec. 10, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 535 | $548.51 | 866,345.0000 | 22,711,420 | 0.06% | 0.00% |
| Dec. 10, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 624 | $547.75 | 866,880.0000 | 22,711,420 | 0.07% | 0.00% |
| Dec. 10, 2025 | FRIEDMAN PAUL A | Director | M | Common Stock | 24800 | $15.80 | 867,504.0000 | 22,711,420 | 2.94% | 0.11% |
| Dec. 3, 2025 | Sibold William John | President and CEO | M | Common Stock | 50000 | $0.00 | 152,474.0000 | 22,711,420 | 48.79% | 0.22% |
| Dec. 4, 2025 | Sibold William John | President and CEO | S | Common Stock | 2400 | $575.34 | 150,074.0000 | 22,711,420 | 1.57% | 0.01% |
| Dec. 3, 2025 | Sibold William John | President and CEO | M | Performance Restricted Stock Units | 50000 | $0.00 | 0.0000 | 22,711,420 | 100.00% | 0.22% |
| Dec. 2, 2025 | Dier Mardi | EVP and CFO | S | Common Stock | 80 | $596.19 | 10,440.0000 | 22,711,420 | 0.76% | 0.00% |
| Dec. 2, 2025 | Dier Mardi | EVP and CFO | M | Stock Option (Right to Buy) | 4173 | $0.00 | 9,180.0000 | 22,711,420 | 31.25% | 0.02% |
| Dec. 2, 2025 | Dier Mardi | EVP and CFO | S | Common Stock | 717 | $574.00 | 12,812.0000 | 22,711,420 | 5.30% | 0.00% |
| Dec. 2, 2025 | Dier Mardi | EVP and CFO | S | Common Stock | 354 | $573.02 | 13,529.0000 | 22,711,420 | 2.55% | 0.00% |
| Dec. 2, 2025 | Dier Mardi | EVP and CFO | S | Common Stock | 120 | $574.95 | 12,692.0000 | 22,711,420 | 0.94% | 0.00% |
| Dec. 2, 2025 | Dier Mardi | EVP and CFO | S | Common Stock | 240 | $576.15 | 12,452.0000 | 22,711,420 | 1.89% | 0.00% |
| Dec. 2, 2025 | Dier Mardi | EVP and CFO | S | Common Stock | 320 | $577.81 | 12,132.0000 | 22,711,420 | 2.57% | 0.00% |
| Dec. 2, 2025 | Dier Mardi | EVP and CFO | S | Common Stock | 258 | $578.83 | 11,874.0000 | 22,711,420 | 2.13% | 0.00% |
| Dec. 2, 2025 | Dier Mardi | EVP and CFO | S | Common Stock | 160 | $589.65 | 10,754.0000 | 22,711,420 | 1.47% | 0.00% |
| Dec. 2, 2025 | Dier Mardi | EVP and CFO | S | Common Stock | 240 | $587.85 | 10,914.0000 | 22,711,420 | 2.15% | 0.00% |
| Dec. 2, 2025 | Dier Mardi | EVP and CFO | S | Common Stock | 240 | $585.44 | 11,154.0000 | 22,711,420 | 2.11% | 0.00% |
| Dec. 2, 2025 | Dier Mardi | EVP and CFO | S | Common Stock | 410 | $571.99 | 13,883.0000 | 22,711,420 | 2.87% | 0.00% |
| Dec. 2, 2025 | Dier Mardi | EVP and CFO | S | Common Stock | 160 | $590.37 | 10,594.0000 | 22,711,420 | 1.49% | 0.00% |
| Dec. 2, 2025 | Dier Mardi | EVP and CFO | S | Common Stock | 74 | $595.20 | 10,520.0000 | 22,711,420 | 0.70% | 0.00% |
| Dec. 2, 2025 | Dier Mardi | EVP and CFO | M | Common Stock | 4173 | $251.63 | 14,613.0000 | 22,711,420 | 39.97% | 0.02% |
| Dec. 2, 2025 | Dier Mardi | EVP and CFO | S | Common Stock | 320 | $570.39 | 14,293.0000 | 22,711,420 | 2.19% | 0.00% |
| Dec. 2, 2025 | Dier Mardi | EVP and CFO | S | Common Stock | 480 | $579.85 | 11,394.0000 | 22,711,420 | 4.04% | 0.00% |
| Nov. 21, 2025 | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 40 | $549.34 | 10,792.0000 | 22,711,420 | 0.37% | 0.00% |
| Nov. 21, 2025 | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 200 | $552.38 | 10,592.0000 | 22,711,420 | 1.85% | 0.00% |
| Nov. 21, 2025 | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 40 | $553.23 | 10,552.0000 | 22,711,420 | 0.38% | 0.00% |
| Nov. 21, 2025 | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 120 | $556.04 | 10,432.0000 | 22,711,420 | 1.14% | 0.00% |
| Nov. 21, 2025 | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 200 | $559.60 | 10,232.0000 | 22,711,420 | 1.92% | 0.00% |
| Nov. 21, 2025 | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 80 | $560.62 | 10,152.0000 | 22,711,420 | 0.78% | 0.00% |
| Nov. 21, 2025 | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 40 | $563.21 | 10,112.0000 | 22,711,420 | 0.39% | 0.00% |
| Nov. 21, 2025 | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 80 | $564.57 | 10,032.0000 | 22,711,420 | 0.79% | 0.00% |
| Nov. 21, 2025 | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 894 | $550.97 | 11,096.0000 | 22,711,420 | 7.46% | 0.00% |
| Nov. 21, 2025 | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 144 | $547.27 | 10,952.0000 | 22,711,420 | 1.30% | 0.00% |
| Nov. 21, 2025 | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 120 | $548.71 | 10,832.0000 | 22,711,420 | 1.10% | 0.00% |
| Nov. 13, 2025 | Levy Richard S | Director | M | Stock Option (Right to Buy) | 6000 | $0.00 | 4,000.0000 | 22,711,420 | 60.00% | 0.03% |
| Nov. 13, 2025 | Levy Richard S | Director | S | Common Stock | 146 | $514.67 | 29,551.0000 | 22,711,420 | 0.49% | 0.00% |
| Nov. 13, 2025 | Levy Richard S | Director | S | Common Stock | 919 | $515.64 | 28,632.0000 | 22,711,420 | 3.11% | 0.00% |
| Nov. 13, 2025 | Levy Richard S | Director | S | Common Stock | 645 | $517.51 | 27,987.0000 | 22,711,420 | 2.25% | 0.00% |
| Nov. 13, 2025 | Levy Richard S | Director | S | Common Stock | 835 | $518.53 | 27,152.0000 | 22,711,420 | 2.98% | 0.00% |
| Nov. 13, 2025 | Levy Richard S | Director | S | Common Stock | 1355 | $519.67 | 25,797.0000 | 22,711,420 | 4.99% | 0.01% |
| Nov. 13, 2025 | Levy Richard S | Director | S | Common Stock | 308 | $520.68 | 25,489.0000 | 22,711,420 | 1.19% | 0.00% |
| Nov. 13, 2025 | Levy Richard S | Director | S | Common Stock | 1094 | $521.79 | 24,395.0000 | 22,711,420 | 4.29% | 0.00% |
| Nov. 13, 2025 | Levy Richard S | Director | S | Common Stock | 1434 | $522.70 | 22,961.0000 | 22,711,420 | 5.88% | 0.01% |
| Nov. 13, 2025 | Levy Richard S | Director | S | Common Stock | 811 | $523.66 | 22,150.0000 | 22,711,420 | 3.53% | 0.00% |
| Nov. 13, 2025 | Levy Richard S | Director | S | Common Stock | 153 | $524.49 | 21,997.0000 | 22,711,420 | 0.69% | 0.00% |
| Nov. 13, 2025 | Levy Richard S | Director | S | Common Stock | 120 | $526.68 | 21,877.0000 | 22,711,420 | 0.55% | 0.00% |
| Nov. 13, 2025 | Levy Richard S | Director | S | Common Stock | 200 | $527.85 | 21,677.0000 | 22,711,420 | 0.91% | 0.00% |
| Nov. 13, 2025 | Levy Richard S | Director | S | Common Stock | 440 | $528.60 | 21,237.0000 | 22,711,420 | 2.03% | 0.00% |
| Nov. 13, 2025 | Levy Richard S | Director | S | Common Stock | 40 | $530.21 | 21,197.0000 | 22,711,420 | 0.19% | 0.00% |
| Nov. 13, 2025 | Levy Richard S | Director | M | Stock Option (Right to Buy) | 2500 | $0.00 | 2,500.0000 | 22,711,420 | 50.00% | 0.01% |
| Nov. 13, 2025 | Levy Richard S | Director | M | Common Stock | 6000 | $16.46 | 29,697.0000 | 22,711,420 | 25.32% | 0.03% |
| Nov. 13, 2025 | Levy Richard S | Director | M | Common Stock | 2500 | $7.36 | 23,697.0000 | 22,711,420 | 11.79% | 0.01% |
| Nov. 5, 2025 | BATE KENNETH | Director | M | Stock Option (Right to Buy) | 10000 | $0.00 | 0.0000 | 22,711,420 | 100.00% | 0.04% |
| Nov. 5, 2025 | BATE KENNETH | Director | M | Stock Option (Right to Buy) | 1105 | $0.00 | 0.0000 | 22,711,420 | 100.00% | 0.00% |
| Nov. 5, 2025 | BATE KENNETH | Director | M | Common Stock | 5470 | $9.45 | 8,097.0000 | 22,711,420 | 208.22% | 0.02% |
| Nov. 5, 2025 | BATE KENNETH | Director | M | Common Stock | 10000 | $303.79 | 18,097.0000 | 22,711,420 | 123.50% | 0.04% |
| Nov. 5, 2025 | BATE KENNETH | Director | M | Common Stock | 1105 | $280.04 | 19,202.0000 | 22,711,420 | 6.11% | 0.00% |
| Nov. 5, 2025 | BATE KENNETH | Director | S | Common Stock | 1763 | $480.24 | 17,439.0000 | 22,711,420 | 9.18% | 0.01% |
| Nov. 5, 2025 | BATE KENNETH | Director | S | Common Stock | 3259 | $481.13 | 14,180.0000 | 22,711,420 | 18.69% | 0.01% |
| Nov. 5, 2025 | BATE KENNETH | Director | S | Common Stock | 1284 | $482.41 | 12,896.0000 | 22,711,420 | 9.06% | 0.01% |
| Nov. 5, 2025 | BATE KENNETH | Director | S | Common Stock | 2069 | $483.41 | 10,827.0000 | 22,711,420 | 16.04% | 0.01% |
| Nov. 5, 2025 | BATE KENNETH | Director | S | Common Stock | 1931 | $484.78 | 8,896.0000 | 22,711,420 | 17.84% | 0.01% |
| Nov. 5, 2025 | BATE KENNETH | Director | S | Common Stock | 1008 | $485.54 | 7,888.0000 | 22,711,420 | 11.33% | 0.00% |
| Nov. 5, 2025 | BATE KENNETH | Director | S | Common Stock | 827 | $486.73 | 7,061.0000 | 22,711,420 | 10.48% | 0.00% |
| Nov. 5, 2025 | BATE KENNETH | Director | S | Common Stock | 2775 | $487.49 | 4,286.0000 | 22,711,420 | 39.30% | 0.01% |
| Nov. 5, 2025 | BATE KENNETH | Director | S | Common Stock | 696 | $489.09 | 3,590.0000 | 22,711,420 | 16.24% | 0.00% |
| Nov. 5, 2025 | BATE KENNETH | Director | S | Common Stock | 933 | $489.95 | 2,657.0000 | 22,711,420 | 25.99% | 0.00% |
| Nov. 5, 2025 | BATE KENNETH | Director | S | Common Stock | 30 | $490.98 | 2,627.0000 | 22,711,420 | 1.13% | 0.00% |
| Nov. 5, 2025 | BATE KENNETH | Director | M | Stock Option (Right to Buy) | 5470 | $0.00 | 0.0000 | 22,711,420 | 100.00% | 0.02% |
| Sept. 9, 2025 | Sibold William John | President and CEO | S | Common Stock | 7279 | $445.63 | 102,474.0000 | 22,080,246 | 6.63% | 0.03% |
| Aug. 21, 2025 | Sibold William John | President and CEO | S | Common Stock | 1131 | $401.00 | 109,753.0000 | 22,080,246 | 1.02% | 0.01% |
| Aug. 21, 2025 | Sibold William John | President and CEO | S | Common Stock | 6485 | $400.03 | 110,884.0000 | 22,080,246 | 5.53% | 0.03% |
| Aug. 18, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 1923 | $353.88 | 1,798,184.0000 | 22,080,246 | 0.11% | 0.01% |
| Aug. 20, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 9362 | $392.24 | 1,947,968.0000 | 22,080,246 | 0.48% | 0.04% |
| Aug. 20, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 862 | $392.24 | 202,813.0000 | 22,080,246 | 0.43% | 0.00% |
| Aug. 20, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 2506 | $389.89 | 1,938,606.0000 | 22,080,246 | 0.13% | 0.01% |
| Aug. 20, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 231 | $389.89 | 201,951.0000 | 22,080,246 | 0.11% | 0.00% |
| Aug. 20, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 366 | $389.00 | 1,936,100.0000 | 22,080,246 | 0.02% | 0.00% |
| Aug. 20, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 34 | $389.00 | 201,720.0000 | 22,080,246 | 0.02% | 0.00% |
| Aug. 20, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 4441 | $387.07 | 1,935,734.0000 | 22,080,246 | 0.23% | 0.02% |
| Aug. 20, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 409 | $387.07 | 201,686.0000 | 22,080,246 | 0.20% | 0.00% |
| Aug. 20, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 13545 | $385.06 | 1,931,293.0000 | 22,080,246 | 0.71% | 0.06% |
| Aug. 20, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 1248 | $385.06 | 201,277.0000 | 22,080,246 | 0.62% | 0.01% |
| Aug. 20, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 4049 | $383.79 | 1,917,748.0000 | 22,080,246 | 0.21% | 0.02% |
| Aug. 20, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 373 | $383.79 | 200,029.0000 | 22,080,246 | 0.19% | 0.00% |
| Aug. 20, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 2838 | $382.82 | 1,913,699.0000 | 22,080,246 | 0.15% | 0.01% |
| Aug. 20, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 262 | $382.82 | 199,656.0000 | 22,080,246 | 0.13% | 0.00% |
| Aug. 20, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 1136 | $382.29 | 1,910,861.0000 | 22,080,246 | 0.06% | 0.01% |
| Aug. 20, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 105 | $382.29 | 199,394.0000 | 22,080,246 | 0.05% | 0.00% |
| Aug. 20, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 9477 | $381.12 | 1,909,725.0000 | 22,080,246 | 0.50% | 0.04% |
| Aug. 20, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 873 | $381.12 | 199,289.0000 | 22,080,246 | 0.44% | 0.00% |
| Aug. 20, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 1919 | $380.78 | 1,900,248.0000 | 22,080,246 | 0.10% | 0.01% |
| Aug. 20, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 176 | $380.78 | 198,416.0000 | 22,080,246 | 0.09% | 0.00% |
| Aug. 20, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 5209 | $380.44 | 1,898,329.0000 | 22,080,246 | 0.28% | 0.02% |
| Aug. 20, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 480 | $380.44 | 198,240.0000 | 22,080,246 | 0.24% | 0.00% |
| Aug. 18, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 7325 | $374.43 | 1,893,120.0000 | 22,080,246 | 0.39% | 0.03% |
| Aug. 18, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 675 | $374.43 | 197,760.0000 | 22,080,246 | 0.34% | 0.00% |
| Aug. 18, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 26704 | $372.87 | 1,885,795.0000 | 22,080,246 | 1.44% | 0.12% |
| Aug. 18, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 2460 | $372.87 | 197,085.0000 | 22,080,246 | 1.26% | 0.01% |
| Aug. 18, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 10128 | $372.16 | 1,859,091.0000 | 22,080,246 | 0.55% | 0.05% |
| Aug. 18, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 933 | $372.16 | 194,625.0000 | 22,080,246 | 0.48% | 0.00% |
| Aug. 18, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 5494 | $371.01 | 1,848,963.0000 | 22,080,246 | 0.30% | 0.02% |
| Aug. 18, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 506 | $371.01 | 193,692.0000 | 22,080,246 | 0.26% | 0.00% |
| Aug. 18, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 2747 | $369.34 | 1,843,469.0000 | 22,080,246 | 0.15% | 0.01% |
| Aug. 18, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 255 | $363.75 | 192,149.0000 | 22,080,246 | 0.13% | 0.00% |
| Aug. 18, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 2772 | $363.75 | 1,832,216.0000 | 22,080,246 | 0.15% | 0.01% |
| Aug. 18, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 211 | $366.30 | 192,360.0000 | 22,080,246 | 0.11% | 0.00% |
| Aug. 18, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 2289 | $366.30 | 1,834,505.0000 | 22,080,246 | 0.12% | 0.01% |
| Aug. 18, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 442 | $367.77 | 192,802.0000 | 22,080,246 | 0.23% | 0.00% |
| Aug. 18, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 4798 | $367.77 | 1,839,303.0000 | 22,080,246 | 0.26% | 0.02% |
| Aug. 18, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 131 | $368.84 | 192,933.0000 | 22,080,246 | 0.07% | 0.00% |
| Aug. 18, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 1419 | $368.84 | 1,840,722.0000 | 22,080,246 | 0.08% | 0.01% |
| Aug. 18, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 253 | $369.34 | 193,186.0000 | 22,080,246 | 0.13% | 0.00% |
| Aug. 18, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 2472 | $358.21 | 1,809,900.0000 | 22,080,246 | 0.14% | 0.01% |
| Aug. 18, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 228 | $358.21 | 190,093.0000 | 22,080,246 | 0.12% | 0.00% |
| Aug. 18, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 8328 | $357.02 | 1,807,428.0000 | 22,080,246 | 0.46% | 0.04% |
| Aug. 18, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 767 | $357.02 | 189,865.0000 | 22,080,246 | 0.41% | 0.00% |
| Aug. 18, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 916 | $355.00 | 1,799,100.0000 | 22,080,246 | 0.05% | 0.00% |
| Aug. 18, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 84 | $355.00 | 189,098.0000 | 22,080,246 | 0.04% | 0.00% |
| Aug. 18, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 177 | $353.88 | 189,014.0000 | 22,080,246 | 0.09% | 0.00% |
| Aug. 18, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 784 | $359.39 | 190,877.0000 | 22,080,246 | 0.41% | 0.00% |
| Aug. 18, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 8514 | $359.39 | 1,818,414.0000 | 22,080,246 | 0.47% | 0.04% |
| Aug. 18, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 502 | $361.37 | 191,379.0000 | 22,080,246 | 0.26% | 0.00% |
| Aug. 18, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 5443 | $361.37 | 1,823,857.0000 | 22,080,246 | 0.30% | 0.02% |
| Aug. 18, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 515 | $362.39 | 191,894.0000 | 22,080,246 | 0.27% | 0.00% |
| Aug. 18, 2025 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock | 5587 | $362.39 | 1,829,444.0000 | 22,080,246 | 0.31% | 0.03% |
| Aug. 18, 2025 | Kelley Shannon T | General Counsel | S | Common Stock | 458 | $358.66 | 10,019.0000 | 22,080,246 | 4.37% | 0.00% |
| Aug. 18, 2025 | Kelley Shannon T | General Counsel | S | Common Stock | 126 | $369.64 | 9,893.0000 | 22,080,246 | 1.26% | 0.00% |
| Aug. 18, 2025 | Kelley Shannon T | General Counsel | S | Common Stock | 84 | $370.06 | 9,809.0000 | 22,080,246 | 0.85% | 0.00% |
| Aug. 18, 2025 | Kelley Shannon T | General Counsel | S | Common Stock | 84 | $371.35 | 9,725.0000 | 22,080,246 | 0.86% | 0.00% |
| Aug. 18, 2025 | Kelley Shannon T | General Counsel | S | Common Stock | 252 | $372.44 | 9,473.0000 | 22,080,246 | 2.59% | 0.00% |
| Aug. 18, 2025 | Kelley Shannon T | General Counsel | S | Common Stock | 68 | $374.13 | 9,405.0000 | 22,080,246 | 0.72% | 0.00% |
| Aug. 18, 2025 | Kelley Shannon T | General Counsel | S | Common Stock | 190 | $375.75 | 9,215.0000 | 22,080,246 | 2.02% | 0.00% |
| Aug. 18, 2025 | Kelley Shannon T | General Counsel | S | Common Stock | 42 | $376.62 | 9,173.0000 | 22,080,246 | 0.46% | 0.00% |
| Aug. 15, 2025 | BATE KENNETH | Director | M | Common Stock | 10000 | $16.46 | 12,627.0000 | 22,080,246 | 380.66% | 0.05% |
| Aug. 15, 2025 | BATE KENNETH | Director | S | Common Stock | 2317 | $363.41 | 10,310.0000 | 22,080,246 | 18.35% | 0.01% |
| Aug. 15, 2025 | BATE KENNETH | Director | S | Common Stock | 2516 | $364.24 | 7,794.0000 | 22,080,246 | 24.40% | 0.01% |
| Aug. 15, 2025 | BATE KENNETH | Director | S | Common Stock | 2567 | $365.33 | 5,227.0000 | 22,080,246 | 32.94% | 0.01% |
| Aug. 15, 2025 | BATE KENNETH | Director | S | Common Stock | 600 | $366.14 | 4,627.0000 | 22,080,246 | 11.48% | 0.00% |
| Aug. 15, 2025 | BATE KENNETH | Director | S | Common Stock | 1104 | $367.63 | 3,523.0000 | 22,080,246 | 23.86% | 0.00% |
| Aug. 15, 2025 | BATE KENNETH | Director | S | Common Stock | 896 | $368.56 | 2,627.0000 | 22,080,246 | 25.43% | 0.00% |
| Aug. 15, 2025 | BATE KENNETH | Director | M | Stock Option (Right to Buy) | 10000 | $0.00 | 0.0000 | 22,080,246 | 100.00% | 0.05% |
| Aug. 13, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 6788 | $368.34 | 938,580.0000 | 22,080,246 | 0.72% | 0.03% |
| Aug. 13, 2025 | FRIEDMAN PAUL A | Director | M | Common Stock | 129172 | $9.45 | 971,876.0000 | 22,080,246 | 15.33% | 0.59% |
| Aug. 13, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 1600 | $358.23 | 970,276.0000 | 22,080,246 | 0.16% | 0.01% |
| Aug. 13, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 455 | $359.31 | 969,821.0000 | 22,080,246 | 0.05% | 0.00% |
| Aug. 13, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 3153 | $360.27 | 966,668.0000 | 22,080,246 | 0.33% | 0.01% |
| Aug. 13, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 1754 | $361.13 | 964,914.0000 | 22,080,246 | 0.18% | 0.01% |
| Aug. 13, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 1439 | $362.29 | 963,475.0000 | 22,080,246 | 0.15% | 0.01% |
| Aug. 13, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 2591 | $363.08 | 960,884.0000 | 22,080,246 | 0.27% | 0.01% |
| Aug. 13, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 3529 | $364.02 | 957,355.0000 | 22,080,246 | 0.37% | 0.02% |
| Aug. 13, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 1716 | $365.19 | 955,639.0000 | 22,080,246 | 0.18% | 0.01% |
| Aug. 13, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 3152 | $366.22 | 952,487.0000 | 22,080,246 | 0.33% | 0.01% |
| Aug. 13, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 7119 | $367.31 | 945,368.0000 | 22,080,246 | 0.75% | 0.03% |
| Aug. 13, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 7992 | $369.44 | 930,588.0000 | 22,080,246 | 0.85% | 0.04% |
| Aug. 13, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 7877 | $370.44 | 922,711.0000 | 22,080,246 | 0.85% | 0.04% |
| Aug. 13, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 22710 | $371.53 | 900,001.0000 | 22,080,246 | 2.46% | 0.10% |
| Aug. 13, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 28976 | $372.39 | 871,025.0000 | 22,080,246 | 3.22% | 0.13% |
| Aug. 13, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 24166 | $373.35 | 846,859.0000 | 22,080,246 | 2.77% | 0.11% |
| Aug. 13, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 4155 | $374.38 | 842,704.0000 | 22,080,246 | 0.49% | 0.02% |
| Aug. 13, 2025 | FRIEDMAN PAUL A | Director | M | Stock Option (Right to Buy) | 129172 | $0.00 | 0.0000 | 22,080,246 | 100.00% | 0.59% |
| Aug. 11, 2025 | FRIEDMAN PAUL A | Director | M | Common Stock | 3203 | $9.45 | 845,907.0000 | 22,080,246 | 0.38% | 0.01% |
| Aug. 11, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 2903 | $350.19 | 843,004.0000 | 22,080,246 | 0.34% | 0.01% |
| Aug. 11, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 300 | $351.04 | 842,704.0000 | 22,080,246 | 0.04% | 0.00% |
| Aug. 12, 2025 | FRIEDMAN PAUL A | Director | M | Common Stock | 43605 | $9.45 | 886,309.0000 | 22,080,246 | 5.17% | 0.20% |
| Aug. 12, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 3303 | $350.93 | 883,006.0000 | 22,080,246 | 0.37% | 0.01% |
| Aug. 12, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 3202 | $351.59 | 879,804.0000 | 22,080,246 | 0.36% | 0.01% |
| Aug. 12, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 1382 | $352.61 | 878,422.0000 | 22,080,246 | 0.16% | 0.01% |
| Aug. 12, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 4768 | $354.06 | 873,654.0000 | 22,080,246 | 0.54% | 0.02% |
| Aug. 12, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 6546 | $355.00 | 867,108.0000 | 22,080,246 | 0.75% | 0.03% |
| Aug. 12, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 5244 | $355.97 | 861,864.0000 | 22,080,246 | 0.60% | 0.02% |
| Aug. 12, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 5094 | $356.94 | 856,770.0000 | 22,080,246 | 0.59% | 0.02% |
| Aug. 12, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 8434 | $357.93 | 848,336.0000 | 22,080,246 | 0.98% | 0.04% |
| Aug. 12, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 5032 | $358.83 | 843,304.0000 | 22,080,246 | 0.59% | 0.02% |
| Aug. 12, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 600 | $359.81 | 842,704.0000 | 22,080,246 | 0.07% | 0.00% |
| Aug. 11, 2025 | FRIEDMAN PAUL A | Director | M | Stock Option (Right to Buy) | 3203 | $0.00 | 172,777.0000 | 22,080,246 | 1.82% | 0.01% |
| Aug. 12, 2025 | FRIEDMAN PAUL A | Director | M | Stock Option (Right to Buy) | 43605 | $0.00 | 129,172.0000 | 22,080,246 | 25.24% | 0.20% |
| Aug. 11, 2025 | Taub Rebecca | Director | M | Common Stock | 3200 | $9.45 | 1,119,784.0000 | 22,080,246 | 0.29% | 0.01% |
| Aug. 11, 2025 | Taub Rebecca | Director | S | Common Stock | 2980 | $350.18 | 1,116,804.0000 | 22,080,246 | 0.27% | 0.01% |
| Aug. 11, 2025 | Taub Rebecca | Director | S | Common Stock | 220 | $351.02 | 1,116,584.0000 | 22,080,246 | 0.02% | 0.00% |
| Aug. 12, 2025 | Taub Rebecca | Director | M | Common Stock | 43263 | $9.45 | 1,159,847.0000 | 22,080,246 | 3.87% | 0.20% |
| Aug. 12, 2025 | Taub Rebecca | Director | S | Common Stock | 3580 | $350.87 | 1,156,267.0000 | 22,080,246 | 0.31% | 0.02% |
| Aug. 12, 2025 | Taub Rebecca | Director | S | Common Stock | 2870 | $351.60 | 1,153,397.0000 | 22,080,246 | 0.25% | 0.01% |
| Aug. 12, 2025 | Taub Rebecca | Director | S | Common Stock | 1175 | $352.45 | 1,152,222.0000 | 22,080,246 | 0.10% | 0.01% |
| Aug. 12, 2025 | Taub Rebecca | Director | S | Common Stock | 4587 | $354.04 | 1,147,635.0000 | 22,080,246 | 0.40% | 0.02% |
| Aug. 12, 2025 | Taub Rebecca | Director | S | Common Stock | 6479 | $354.97 | 1,141,156.0000 | 22,080,246 | 0.56% | 0.03% |
| Aug. 12, 2025 | Taub Rebecca | Director | S | Common Stock | 5752 | $355.95 | 1,135,404.0000 | 22,080,246 | 0.50% | 0.03% |
| Aug. 12, 2025 | Taub Rebecca | Director | S | Common Stock | 4864 | $356.88 | 1,130,540.0000 | 22,080,246 | 0.43% | 0.02% |
| Aug. 12, 2025 | Taub Rebecca | Director | S | Common Stock | 6715 | $357.85 | 1,123,825.0000 | 22,080,246 | 0.59% | 0.03% |
| Aug. 12, 2025 | Taub Rebecca | Director | S | Common Stock | 6541 | $358.81 | 1,117,284.0000 | 22,080,246 | 0.58% | 0.03% |
| Aug. 12, 2025 | Taub Rebecca | Director | S | Common Stock | 700 | $359.71 | 1,116,584.0000 | 22,080,246 | 0.06% | 0.00% |
| Aug. 11, 2025 | Taub Rebecca | Director | M | Stock Option (Right to Buy) | 3200 | $0.00 | 43,263.0000 | 22,080,246 | 6.89% | 0.01% |
| Aug. 12, 2025 | Taub Rebecca | Director | M | Stock Option (Right to Buy) | 43263 | $0.00 | 0.0000 | 22,080,246 | 100.00% | 0.20% |
| Aug. 1, 2025 | Brennan Daniel J. | Director | A | Stock Option (Right to Buy) | 1705 | $0.00 | 1,705.0000 | 22,080,246 | 9999.99% | 0.01% |
| Aug. 1, 2025 | Brennan Daniel J. | Director | A | Common Stock | 967 | $0.00 | 967.0000 | 22,080,246 | 9999.99% | 0.00% |
| July 18, 2025 | Taub Rebecca | Director | S | Common Stock | 1000 | $350.01 | 1,116,584.0000 | 22,080,246 | 0.09% | 0.00% |
| July 18, 2025 | Taub Rebecca | Director | M | Stock Option (Right to Buy) | 1000 | $0.00 | 46,463.0000 | 22,080,246 | 2.11% | 0.00% |
| July 18, 2025 | FRIEDMAN PAUL A | Director | M | Common Stock | 1400 | $9.45 | 844,104.0000 | 22,080,246 | 0.17% | 0.01% |
| July 18, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 1400 | $350.03 | 842,704.0000 | 22,080,246 | 0.17% | 0.01% |
| July 18, 2025 | FRIEDMAN PAUL A | Director | M | Stock Option (Right to Buy) | 1400 | $0.00 | 175,980.0000 | 22,080,246 | 0.79% | 0.01% |
| July 18, 2025 | Taub Rebecca | Director | M | Common Stock | 1000 | $9.45 | 1,117,584.0000 | 22,080,246 | 0.09% | 0.00% |
| July 16, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 1200 | $356.62 | 842,704.0000 | 22,080,246 | 0.14% | 0.01% |
| July 17, 2025 | FRIEDMAN PAUL A | Director | M | Common Stock | 2700 | $9.45 | 845,404.0000 | 22,080,246 | 0.32% | 0.01% |
| July 17, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 2000 | $350.10 | 843,404.0000 | 22,080,246 | 0.24% | 0.01% |
| July 17, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 700 | $351.57 | 842,704.0000 | 22,080,246 | 0.08% | 0.00% |
| July 16, 2025 | FRIEDMAN PAUL A | Director | M | Stock Option (Right to Buy) | 26176 | $0.00 | 180,080.0000 | 22,080,246 | 12.69% | 0.12% |
| July 17, 2025 | FRIEDMAN PAUL A | Director | M | Stock Option (Right to Buy) | 2700 | $0.00 | 177,380.0000 | 22,080,246 | 1.50% | 0.01% |
| July 16, 2025 | Taub Rebecca | Director | M | Common Stock | 26444 | $9.45 | 1,143,028.0000 | 22,080,246 | 2.37% | 0.12% |
| July 16, 2025 | Taub Rebecca | Director | S | Common Stock | 6000 | $350.19 | 1,137,028.0000 | 22,080,246 | 0.52% | 0.03% |
| July 16, 2025 | Taub Rebecca | Director | S | Common Stock | 1897 | $351.37 | 1,135,131.0000 | 22,080,246 | 0.17% | 0.01% |
| July 16, 2025 | Taub Rebecca | Director | S | Common Stock | 2357 | $352.64 | 1,132,774.0000 | 22,080,246 | 0.21% | 0.01% |
| July 16, 2025 | Taub Rebecca | Director | S | Common Stock | 2569 | $353.82 | 1,130,205.0000 | 22,080,246 | 0.23% | 0.01% |
| July 16, 2025 | Taub Rebecca | Director | S | Common Stock | 5800 | $354.61 | 1,124,405.0000 | 22,080,246 | 0.51% | 0.03% |
| July 16, 2025 | Taub Rebecca | Director | S | Common Stock | 6441 | $355.61 | 1,117,964.0000 | 22,080,246 | 0.57% | 0.03% |
| July 16, 2025 | Taub Rebecca | Director | S | Common Stock | 1380 | $356.52 | 1,116,584.0000 | 22,080,246 | 0.12% | 0.01% |
| July 17, 2025 | Taub Rebecca | Director | M | Common Stock | 2657 | $9.45 | 1,119,241.0000 | 22,080,246 | 0.24% | 0.01% |
| July 17, 2025 | Taub Rebecca | Director | S | Common Stock | 2057 | $350.09 | 1,117,184.0000 | 22,080,246 | 0.18% | 0.01% |
| July 17, 2025 | Taub Rebecca | Director | S | Common Stock | 600 | $351.50 | 1,116,584.0000 | 22,080,246 | 0.05% | 0.00% |
| July 17, 2025 | Taub Rebecca | Director | M | Stock Option (Right to Buy) | 2657 | $0.00 | 47,463.0000 | 22,080,246 | 5.30% | 0.01% |
| July 16, 2025 | Taub Rebecca | Director | M | Stock Option (Right to Buy) | 26444 | $0.00 | 50,120.0000 | 22,080,246 | 34.54% | 0.12% |
| July 16, 2025 | FRIEDMAN PAUL A | Director | M | Common Stock | 26176 | $9.45 | 868,880.0000 | 22,080,246 | 3.11% | 0.12% |
| July 16, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 5541 | $350.17 | 863,339.0000 | 22,080,246 | 0.64% | 0.03% |
| July 16, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 2371 | $351.38 | 860,968.0000 | 22,080,246 | 0.27% | 0.01% |
| July 16, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 2110 | $352.67 | 858,858.0000 | 22,080,246 | 0.25% | 0.01% |
| July 16, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 2319 | $353.82 | 856,539.0000 | 22,080,246 | 0.27% | 0.01% |
| July 16, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 6851 | $354.65 | 849,688.0000 | 22,080,246 | 0.80% | 0.03% |
| July 16, 2025 | FRIEDMAN PAUL A | Director | S | Common Stock | 5784 | $355.61 | 843,904.0000 | 22,080,246 | 0.68% | 0.03% |
| June 20, 2025 | Daly James M | Director | A | Stock Option (Right to Buy) | 1290 | $0.00 | 1,290.0000 | 22,080,246 | 9999.99% | 0.01% |
| June 20, 2025 | BATE KENNETH | Director | A | Common Stock | 715 | $0.00 | 2,627.0000 | 22,080,246 | 37.40% | 0.00% |
| June 20, 2025 | BATE KENNETH | Director | A | Stock Option (Right to Buy) | 1290 | $0.00 | 1,290.0000 | 22,080,246 | 9999.99% | 0.01% |
| June 20, 2025 | Levy Richard S | Director | A | Common Stock | 715 | $0.00 | 21,197.0000 | 22,080,246 | 3.49% | 0.00% |
| June 20, 2025 | Levy Richard S | Director | A | Stock Option (Right to Buy) | 1290 | $0.00 | 1,290.0000 | 22,080,246 | 9999.99% | 0.01% |
| June 20, 2025 | FOUSE JACQUALYN A | Director | A | Common Stock | 203 | $0.00 | 1,097.0000 | 22,080,246 | 22.71% | 0.00% |
| June 20, 2025 | FOUSE JACQUALYN A | Director | A | Stock Option (Right to Buy) | 366 | $0.00 | 366.0000 | 22,080,246 | 9999.99% | 0.00% |
| June 20, 2025 | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 1430 | $0.00 | 188,837.0000 | 22,080,246 | 0.76% | 0.01% |
| June 20, 2025 | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 1430 | $0.00 | 1,796,261.0000 | 22,080,246 | 0.08% | 0.01% |
| June 20, 2025 | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Options (right to buy) | 2580 | $0.00 | 2,580.0000 | 22,080,246 | 9999.99% | 0.01% |
| June 20, 2025 | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Options (right to buy) | 2580 | $0.00 | 2,580.0000 | 22,080,246 | 9999.99% | 0.01% |
| June 20, 2025 | Daly James M | Director | A | Common Stock | 715 | $0.00 | 2,627.0000 | 22,080,246 | 37.40% | 0.00% |
| June 20, 2025 | FRIEDMAN PAUL A | Director | A | Common Stock | 715 | $0.00 | 842,704.0000 | 22,080,246 | 0.08% | 0.00% |
| June 20, 2025 | FRIEDMAN PAUL A | Director | A | Stock Option (Right to Buy) | 1290 | $0.00 | 1,290.0000 | 22,080,246 | 9999.99% | 0.01% |
| May 15, 2025 | Soergel David | Chief Medical Officer | A | Common Stock | 7545 | $0.00 | 7,545.0000 | 22,080,246 | 9999.99% | 0.03% |
| May 15, 2025 | Soergel David | Chief Medical Officer | A | Stock Option (Right to Buy) | 12839 | $0.00 | 12,839.0000 | 22,080,246 | 9999.99% | 0.06% |
| April 10, 2025 | Levy Richard S | Director | M | Common Stock | 9470 | $65.06 | 20,482.0000 | 22,080,246 | 86.00% | 0.04% |
| April 10, 2025 | Levy Richard S | Director | M | Stock Option (Right to Buy) | 9470 | $0.00 | 0.0000 | 22,080,246 | 100.00% | 0.04% |
| March 12, 2025 | CRAVES FRED B | Director | S | Common Stock | 2759 | $331.36 | 386,929.0000 | 22,080,246 | 0.71% | 0.01% |
| March 12, 2025 | CRAVES FRED B | Director | S | Common Stock | 2382 | $332.38 | 384,547.0000 | 22,080,246 | 0.62% | 0.01% |
| March 12, 2025 | CRAVES FRED B | Director | S | Common Stock | 800 | $333.66 | 383,747.0000 | 22,080,246 | 0.21% | 0.00% |
| March 12, 2025 | CRAVES FRED B | Director | S | Common Stock | 200 | $334.97 | 383,547.0000 | 22,080,246 | 0.05% | 0.00% |
| March 13, 2025 | CRAVES FRED B | Director | M | Common Stock | 7742 | $65.06 | 391,289.0000 | 22,080,246 | 2.02% | 0.04% |
| March 13, 2025 | CRAVES FRED B | Director | S | Common Stock | 1951 | $322.45 | 389,338.0000 | 22,080,246 | 0.50% | 0.01% |
| March 13, 2025 | CRAVES FRED B | Director | S | Common Stock | 1649 | $323.47 | 387,689.0000 | 22,080,246 | 0.42% | 0.01% |
| March 13, 2025 | CRAVES FRED B | Director | S | Common Stock | 900 | $324.69 | 386,789.0000 | 22,080,246 | 0.23% | 0.00% |
| March 13, 2025 | CRAVES FRED B | Director | S | Common Stock | 800 | $325.63 | 385,989.0000 | 22,080,246 | 0.21% | 0.00% |
| March 13, 2025 | CRAVES FRED B | Director | S | Common Stock | 1000 | $327.63 | 384,989.0000 | 22,080,246 | 0.26% | 0.00% |
| March 13, 2025 | CRAVES FRED B | Director | S | Common Stock | 400 | $328.68 | 384,589.0000 | 22,080,246 | 0.10% | 0.00% |
| March 13, 2025 | CRAVES FRED B | Director | S | Common Stock | 967 | $329.86 | 383,622.0000 | 22,080,246 | 0.25% | 0.00% |
| March 13, 2025 | CRAVES FRED B | Director | S | Common Stock | 75 | $330.23 | 383,547.0000 | 22,080,246 | 0.02% | 0.00% |
| March 12, 2025 | CRAVES FRED B | Director | M | Stock Option (Right to Buy) | 1728 | $0.00 | 7,742.0000 | 22,080,246 | 18.25% | 0.01% |
| March 13, 2025 | CRAVES FRED B | Director | M | Stock Option (Right to Buy) | 7742 | $0.00 | 0.0000 | 22,080,246 | 100.00% | 0.04% |
| March 12, 2025 | CRAVES FRED B | Director | M | Stock Option (Right to Buy) | 6000 | $0.00 | 0.0000 | 22,080,246 | 100.00% | 0.03% |
| March 12, 2025 | CRAVES FRED B | Director | M | Common Stock | 1728 | $65.06 | 385,275.0000 | 22,080,246 | 0.45% | 0.01% |
| March 12, 2025 | CRAVES FRED B | Director | M | Common Stock | 6000 | $111.06 | 391,275.0000 | 22,080,246 | 1.56% | 0.03% |
| March 12, 2025 | CRAVES FRED B | Director | S | Common Stock | 1587 | $330.54 | 389,688.0000 | 22,080,246 | 0.41% | 0.01% |
| March 10, 2025 | Dier Mardi | SVP and CFO | S | Common Stock | 258 | $323.04 | 10,440.0000 | 22,080,246 | 2.41% | 0.00% |
| March 10, 2025 | FOUSE JACQUALYN A | Director | A | Stock Option (Right to Buy) | 1579 | $0.00 | 1,579.0000 | 22,080,246 | 9999.99% | 0.01% |
| March 10, 2025 | FOUSE JACQUALYN A | Director | A | Common Stock | 894 | $0.00 | 894.0000 | 22,080,246 | 9999.99% | 0.00% |
| March 5, 2025 | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | S | Common Stock | 900 | $335.15 | 16,941.0000 | 22,080,246 | 5.04% | 0.00% |
| March 5, 2025 | Sibold William John | President and CEO | A | Common Stock | 13066 | $0.00 | 117,369.0000 | 22,080,246 | 12.53% | 0.06% |
| March 5, 2025 | Sibold William John | President and CEO | A | Stock Option (Right to Buy) | 22009 | $0.00 | 22,009.0000 | 22,080,246 | 9999.99% | 0.10% |
| March 5, 2025 | Dier Mardi | SVP and CFO | A | Common Stock | 3784 | $0.00 | 10,698.0000 | 22,080,246 | 54.73% | 0.02% |
| March 5, 2025 | Dier Mardi | SVP and CFO | A | Stock Option (Right to Buy) | 6374 | $0.00 | 6,374.0000 | 22,080,246 | 9999.99% | 0.03% |
| March 5, 2025 | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | M | Common Stock | 6825 | $87.92 | 10,553.0000 | 22,080,246 | 183.07% | 0.03% |
| March 5, 2025 | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | M | Common Stock | 7288 | $87.09 | 17,841.0000 | 22,080,246 | 69.06% | 0.03% |
| March 5, 2025 | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | S | Common Stock | 1777 | $336.78 | 15,164.0000 | 22,080,246 | 10.49% | 0.01% |
| March 5, 2025 | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | S | Common Stock | 1146 | $338.09 | 14,018.0000 | 22,080,246 | 7.56% | 0.01% |
| March 5, 2025 | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | S | Common Stock | 400 | $339.68 | 13,618.0000 | 22,080,246 | 2.85% | 0.00% |
| March 5, 2025 | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | S | Common Stock | 1657 | $340.75 | 11,961.0000 | 22,080,246 | 12.17% | 0.01% |
| March 5, 2025 | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | S | Common Stock | 1043 | $341.84 | 10,918.0000 | 22,080,246 | 8.72% | 0.00% |
| March 5, 2025 | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | S | Common Stock | 1077 | $342.90 | 9,841.0000 | 22,080,246 | 9.86% | 0.00% |
| March 5, 2025 | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | S | Common Stock | 4701 | $343.85 | 5,140.0000 | 22,080,246 | 47.77% | 0.02% |
| March 5, 2025 | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | S | Common Stock | 1412 | $344.76 | 3,728.0000 | 22,080,246 | 27.47% | 0.01% |
| March 5, 2025 | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | A | Common Stock | 2061 | $0.00 | 5,789.0000 | 22,080,246 | 55.28% | 0.01% |
| March 5, 2025 | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | M | Stock Option (Right to Buy) | 6825 | $0.00 | 4,375.0000 | 22,080,246 | 60.94% | 0.03% |
| March 5, 2025 | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | M | Stock Option (Right to Buy) | 7288 | $0.00 | 3,062.0000 | 22,080,246 | 70.42% | 0.03% |
| March 5, 2025 | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | A | Stock Option (Right to Buy) | 1157 | $0.00 | 1,157.0000 | 22,080,246 | 9999.99% | 0.01% |
| March 5, 2025 | Taub Rebecca | Pres., R&D, and CMO | A | Common Stock | 4382 | $0.00 | 1,116,584.0000 | 22,080,246 | 0.39% | 0.02% |
| March 5, 2025 | Taub Rebecca | Pres., R&D, and CMO | A | Stock Option (Right to Buy) | 7381 | $0.00 | 7,381.0000 | 22,080,246 | 9999.99% | 0.03% |
| March 5, 2025 | Kelley Shannon T | General Counsel | A | Common Stock | 3187 | $0.00 | 10,477.0000 | 22,080,246 | 43.72% | 0.01% |
| March 5, 2025 | Kelley Shannon T | General Counsel | A | Stock Option (Right to Buy) | 5368 | $0.00 | 5,368.0000 | 22,080,246 | 9999.99% | 0.02% |
| March 5, 2025 | Huntsman Carole | Chief Commercial Officer | A | Common Stock | 3386 | $0.00 | 11,990.0000 | 22,080,246 | 39.35% | 0.02% |
| March 5, 2025 | Huntsman Carole | Chief Commercial Officer | A | Stock Option (Right to Buy) | 5703 | $0.00 | 5,703.0000 | 22,080,246 | 9999.99% | 0.03% |
| March 3, 2025 | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 100 | $326.34 | 9,367.0000 | 22,080,246 | 1.06% | 0.00% |
| March 3, 2025 | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 100 | $329.64 | 9,167.0000 | 22,080,246 | 1.08% | 0.00% |
| March 3, 2025 | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 563 | $335.00 | 8,604.0000 | 22,080,246 | 6.14% | 0.00% |
| March 3, 2025 | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 200 | $324.59 | 9,467.0000 | 22,080,246 | 2.07% | 0.00% |
| March 3, 2025 | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 100 | $327.49 | 9,267.0000 | 22,080,246 | 1.07% | 0.00% |
| March 3, 2025 | Kelley Shannon T | General Counsel | S | Common Stock | 415 | $335.00 | 7,290.0000 | 22,080,246 | 5.39% | 0.00% |
| March 3, 2025 | Dier Mardi | SVP and CFO | S | Common Stock | 1187 | $325.89 | 7,688.0000 | 22,080,246 | 13.37% | 0.01% |
| March 3, 2025 | Dier Mardi | SVP and CFO | S | Common Stock | 774 | $323.54 | 6,914.0000 | 22,080,246 | 10.07% | 0.00% |
| March 3, 2025 | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 71 | $313.08 | 10,367.0000 | 22,080,246 | 0.68% | 0.00% |
| March 3, 2025 | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 200 | $314.74 | 10,167.0000 | 22,080,246 | 1.93% | 0.00% |
| March 3, 2025 | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 300 | $320.21 | 9,867.0000 | 22,080,246 | 2.95% | 0.00% |
| March 3, 2025 | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 200 | $323.65 | 9,667.0000 | 22,080,246 | 2.03% | 0.00% |
| Feb. 28, 2025 | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | S | Common Stock | 1052 | $340.99 | 3,903.0000 | 22,080,246 | 21.23% | 0.00% |
| Feb. 28, 2025 | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | S | Common Stock | 175 | $341.55 | 3,728.0000 | 22,080,246 | 4.48% | 0.00% |
| Feb. 27, 2025 | BATE KENNETH | Director | S | Common Stock | 500 | $351.99 | 21,312.0000 | 22,080,246 | 2.29% | 0.00% |
| Feb. 27, 2025 | BATE KENNETH | Director | S | Common Stock | 238 | $353.83 | 21,074.0000 | 22,080,246 | 1.12% | 0.00% |
| Feb. 27, 2025 | BATE KENNETH | Director | S | Common Stock | 8545 | $355.08 | 12,529.0000 | 22,080,246 | 40.55% | 0.04% |
| Feb. 27, 2025 | BATE KENNETH | Director | S | Common Stock | 2791 | $356.51 | 9,738.0000 | 22,080,246 | 22.28% | 0.01% |
| Feb. 27, 2025 | BATE KENNETH | Director | S | Common Stock | 2038 | $357.27 | 7,700.0000 | 22,080,246 | 20.93% | 0.01% |
| Feb. 27, 2025 | BATE KENNETH | Director | S | Common Stock | 3548 | $358.33 | 4,152.0000 | 22,080,246 | 46.08% | 0.02% |
| Feb. 27, 2025 | BATE KENNETH | Director | S | Common Stock | 2024 | $359.21 | 2,128.0000 | 22,080,246 | 48.75% | 0.01% |
| Feb. 27, 2025 | BATE KENNETH | Director | S | Common Stock | 216 | $360.07 | 1,912.0000 | 22,080,246 | 10.15% | 0.00% |
| Feb. 27, 2025 | BATE KENNETH | Director | M | Stock Option (Right to Buy) | 6000 | $0.00 | 0.0000 | 22,080,246 | 100.00% | 0.03% |
| Feb. 27, 2025 | BATE KENNETH | Director | M | Stock Option (Right to Buy) | 9470 | $0.00 | 0.0000 | 22,080,246 | 100.00% | 0.04% |
| Feb. 27, 2025 | BATE KENNETH | Director | M | Stock Option (Right to Buy) | 4530 | $0.00 | 5,470.0000 | 22,080,246 | 45.30% | 0.02% |
| Feb. 27, 2025 | Sibold William John | President and CEO | M | Common Stock | 50000 | $0.00 | 104,303.0000 | 22,080,246 | 92.08% | 0.23% |
| Feb. 27, 2025 | Sibold William John | President and CEO | M | Performance Restricted Stock Units | 50000 | $0.00 | 0.0000 | 22,080,246 | 100.00% | 0.23% |
| Feb. 27, 2025 | Daly James M | Director | M | Common Stock | 9470 | $65.06 | 11,382.0000 | 22,080,246 | 495.29% | 0.04% |
| Feb. 27, 2025 | Daly James M | Director | M | Common Stock | 6000 | $111.06 | 17,382.0000 | 22,080,246 | 52.71% | 0.03% |
| Feb. 27, 2025 | Daly James M | Director | S | Common Stock | 398 | $346.90 | 16,984.0000 | 22,080,246 | 2.29% | 0.00% |
| Feb. 27, 2025 | Daly James M | Director | S | Common Stock | 14302 | $347.39 | 2,682.0000 | 22,080,246 | 84.21% | 0.06% |
| Feb. 27, 2025 | Daly James M | Director | S | Common Stock | 770 | $348.94 | 1,912.0000 | 22,080,246 | 28.71% | 0.00% |
| Feb. 27, 2025 | Daly James M | Director | M | Stock Option (Right to Buy) | 9470 | $0.00 | 0.0000 | 22,080,246 | 100.00% | 0.04% |
| Feb. 27, 2025 | Daly James M | Director | M | Stock Option (Right to Buy) | 6000 | $0.00 | 0.0000 | 22,080,246 | 100.00% | 0.03% |
| Feb. 27, 2025 | BATE KENNETH | Director | M | Common Stock | 6000 | $111.06 | 7,912.0000 | 22,080,246 | 313.81% | 0.03% |
| Feb. 27, 2025 | BATE KENNETH | Director | M | Common Stock | 9470 | $65.06 | 17,382.0000 | 22,080,246 | 119.69% | 0.04% |
| Feb. 27, 2025 | BATE KENNETH | Director | M | Common Stock | 4530 | $9.45 | 21,912.0000 | 22,080,246 | 26.06% | 0.02% |
| Feb. 27, 2025 | BATE KENNETH | Director | S | Common Stock | 100 | $351.01 | 21,812.0000 | 22,080,246 | 0.46% | 0.00% |
| Jan. 24, 2025 | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | S | Common Stock | 103 | $335.24 | 4,955.0000 | 0 | 2.04% | 0.00% |
| Jan. 24, 2025 | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 347 | $335.24 | 10,438.0000 | 0 | 3.22% | 0.00% |
| Jan. 24, 2025 | Sibold William John | President and CEO | S | Common Stock | 1584 | $335.24 | 54,303.0000 | 0 | 2.83% | 0.00% |
| Jan. 24, 2025 | Taub Rebecca | Pres., R&D, and CMO | S | Common Stock | 648 | $335.24 | 1,112,202.0000 | 0 | 0.06% | 0.00% |
| Jan. 17, 2025 | Taub Rebecca | Pres., R&D, and CMO | S | Common Stock | 1689 | $273.41 | 1,112,850.0000 | 0 | 0.15% | 0.00% |
| Jan. 17, 2025 | Kelley Shannon T | General Counsel | S | Common Stock | 277 | $273.41 | 7,705.0000 | 0 | 3.47% | 0.00% |
| Jan. 17, 2025 | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | S | Common Stock | 442 | $273.41 | 5,058.0000 | 0 | 8.04% | 0.00% |
| Dec. 3, 2024 | CRAVES FRED B | Director | S | Common Stock | 520 | $315.90 | 383,547.0000 | 0 | 0.14% | 0.00% |
| Dec. 3, 2024 | CRAVES FRED B | Director | S | Common Stock | 3080 | $315.21 | 384,067.0000 | 0 | 0.80% | 0.00% |
| Nov. 25, 2024 | CRAVES FRED B | Director | S | Common Stock | 2200 | $350.08 | 388,347.0000 | 0 | 0.56% | 0.00% |
| Nov. 25, 2024 | CRAVES FRED B | Director | S | Common Stock | 1200 | $350.71 | 387,147.0000 | 0 | 0.31% | 0.00% |
| Nov. 21, 2024 | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 688 | $316.92 | 10,785.0000 | 0 | 6.00% | 0.00% |
| Nov. 7, 2024 | Levy Richard S | Not found | M | Common Stock | 5000 | $7.36 | 16,012.0000 | 0 | 45.41% | 0.00% |
| Nov. 7, 2024 | Levy Richard S | Not found | M | Stock Option (Right to Buy) | 5000 | $0.00 | 5,000.0000 | 0 | 50.00% | 0.00% |
| Nov. 7, 2024 | Levy Richard S | Not found | S | Common Stock | 5000 | $350.00 | 11,012.0000 | 0 | 31.23% | 0.00% |
| Nov. 1, 2024 | Levy Richard S | Not found | S | Common Stock | 300 | $304.29 | 11,012.0000 | 0 | 2.65% | 0.00% |
| Nov. 1, 2024 | Levy Richard S | Not found | M | Stock Option (Right to Buy) | 5000 | $0.00 | 10,000.0000 | 0 | 33.33% | 0.00% |
| Nov. 1, 2024 | Levy Richard S | Not found | M | Common Stock | 5000 | $7.36 | 16,012.0000 | 0 | 45.41% | 0.00% |
| Nov. 1, 2024 | Levy Richard S | Not found | S | Common Stock | 2800 | $300.10 | 13,212.0000 | 0 | 17.49% | 0.00% |
| Nov. 1, 2024 | Levy Richard S | Not found | S | Common Stock | 1100 | $301.22 | 12,112.0000 | 0 | 8.33% | 0.00% |
| Nov. 1, 2024 | Levy Richard S | Not found | S | Common Stock | 800 | $302.25 | 11,312.0000 | 0 | 6.61% | 0.00% |
| Sept. 13, 2024 | CRAVES FRED B | Not found | G | Common Stock | 15000 | $0.00 | 390,547.0000 | 0 | 3.70% | 0.00% |
| Sept. 9, 2024 | Sibold William John | President and CEO | S | Common Stock | 6363 | $243.83 | 55,887.0000 | 0 | 10.22% | 0.00% |
| Aug. 15, 2024 | Kelley Shannon T | General Counsel | A | Stock Option (Right to Buy) | 7820 | $0.00 | 7,820.0000 | 0 | 9999.99% | 0.00% |
| Aug. 15, 2024 | Kelley Shannon T | General Counsel | A | Common Stock | 5215 | $0.00 | 7,982.0000 | 0 | 188.47% | 0.00% |
| June 25, 2024 | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Options (right to buy) | 2210 | $0.00 | 2,210.0000 | 0 | 9999.99% | 0.00% |
| June 25, 2024 | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Options (right to buy) | 2210 | $0.00 | 2,210.0000 | 0 | 9999.99% | 0.00% |
| June 25, 2024 | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 1428 | $0.00 | 1,794,831.0000 | 0 | 0.08% | 0.00% |
| June 25, 2024 | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 1428 | $0.00 | 187,407.0000 | 0 | 0.77% | 0.00% |
| June 25, 2024 | FRIEDMAN PAUL A | Not found | A | Stock Option (Right to Buy) | 1105 | $0.00 | 1,105.0000 | 0 | 9999.99% | 0.00% |
| June 25, 2024 | FRIEDMAN PAUL A | Not found | A | Common Stock | 714 | $0.00 | 841,989.0000 | 0 | 0.08% | 0.00% |
| June 25, 2024 | Levy Richard S | Not found | A | Stock Option (Right to Buy) | 1105 | $0.00 | 1,105.0000 | 0 | 9999.99% | 0.00% |
| June 25, 2024 | Levy Richard S | Not found | A | Common Stock | 714 | $0.00 | 11,012.0000 | 0 | 6.93% | 0.00% |
| June 25, 2024 | Daly James M | Not found | A | Stock Option (Right to Buy) | 1105 | $0.00 | 1,105.0000 | 0 | 9999.99% | 0.00% |
| June 25, 2024 | Daly James M | Not found | A | Common Stock | 714 | $0.00 | 1,912.0000 | 0 | 59.60% | 0.00% |
| June 25, 2024 | BATE KENNETH | Not found | A | Stock Option (Right to Buy) | 1105 | $0.00 | 1,105.0000 | 0 | 9999.99% | 0.00% |
| June 25, 2024 | BATE KENNETH | Not found | A | Common Stock | 714 | $0.00 | 1,912.0000 | 0 | 59.60% | 0.00% |
| June 25, 2024 | CRAVES FRED B | Not found | A | Stock Option (Right to Buy) | 1105 | $0.00 | 1,105.0000 | 0 | 9999.99% | 0.00% |
| June 25, 2024 | CRAVES FRED B | Not found | A | Common Stock | 714 | $0.00 | 405,547.0000 | 0 | 0.18% | 0.00% |
| June 14, 2024 | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | M | Stock Option (Right to Buy) | 1900 | $0.00 | 10,350.0000 | 0 | 15.51% | 0.00% |
| June 14, 2024 | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | S | Common Stock | 1900 | $280.00 | 5,500.0000 | 0 | 25.68% | 0.00% |
| June 14, 2024 | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | M | Common Stock | 1900 | $87.09 | 7,400.0000 | 0 | 34.55% | 0.00% |
| June 12, 2024 | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | M | Common Stock | 2000 | $87.92 | 7,500.0000 | 0 | 36.36% | 0.00% |
| June 12, 2024 | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | S | Common Stock | 2000 | $285.00 | 5,500.0000 | 0 | 26.67% | 0.00% |
| June 12, 2024 | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | M | Stock Option (Right to Buy) | 2000 | $0.00 | 15,200.0000 | 0 | 11.63% | 0.00% |
| June 11, 2024 | CRAVES FRED B | Not found | G | Common Stock | 45852 | $0.00 | 404,833.0000 | 0 | 10.17% | 0.00% |
| June 11, 2024 | CRAVES FRED B | Not found | G | Common Stock | 39000 | $0.00 | 404,833.0000 | 0 | 8.79% | 0.00% |
| May 21, 2024 | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | S | Common Stock | 1036 | $231.34 | 5,500.0000 | 0 | 15.85% | 0.00% |
| May 14, 2024 | CRAVES FRED B | Not found | S | Common Stock | 721 | $216.98 | 491,885.0000 | 0 | 0.15% | 0.00% |
| May 14, 2024 | CRAVES FRED B | Not found | S | Common Stock | 1100 | $217.86 | 490,785.0000 | 0 | 0.22% | 0.00% |
| May 14, 2024 | CRAVES FRED B | Not found | S | Common Stock | 1000 | $218.99 | 489,785.0000 | 0 | 0.20% | 0.00% |
| May 14, 2024 | CRAVES FRED B | Not found | S | Common Stock | 100 | $219.90 | 489,685.0000 | 0 | 0.02% | 0.00% |
| May 14, 2024 | CRAVES FRED B | Not found | M | Stock Option (right to buy) | 10000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 14, 2024 | CRAVES FRED B | Not found | M | Stock Option (right to buy) | 12489 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 14, 2024 | CRAVES FRED B | Not found | M | Common Stock | 12489 | $105.08 | 512,174.0000 | 0 | 2.50% | 0.00% |
| May 14, 2024 | CRAVES FRED B | Not found | M | Common Stock | 10000 | $100.45 | 499,685.0000 | 0 | 2.04% | 0.00% |
| May 14, 2024 | CRAVES FRED B | Not found | S | Common Stock | 8827 | $210.99 | 503,347.0000 | 0 | 1.72% | 0.00% |
| May 14, 2024 | CRAVES FRED B | Not found | S | Common Stock | 5009 | $211.84 | 498,338.0000 | 0 | 1.00% | 0.00% |
| May 14, 2024 | CRAVES FRED B | Not found | S | Common Stock | 1363 | $212.85 | 496,975.0000 | 0 | 0.27% | 0.00% |
| May 14, 2024 | CRAVES FRED B | Not found | S | Common Stock | 2190 | $213.85 | 494,785.0000 | 0 | 0.44% | 0.00% |
| May 14, 2024 | CRAVES FRED B | Not found | S | Common Stock | 1804 | $214.68 | 492,981.0000 | 0 | 0.36% | 0.00% |
| May 14, 2024 | CRAVES FRED B | Not found | S | Common Stock | 375 | $216.08 | 492,606.0000 | 0 | 0.08% | 0.00% |
| April 8, 2024 | FRIEDMAN PAUL A | Not found | M | Stock Option (Right to Buy) | 26270 | $0.00 | 206,256.0000 | 0 | 11.30% | 0.00% |
| April 8, 2024 | FRIEDMAN PAUL A | Not found | M | Common Stock | 26270 | $9.45 | 867,545.0000 | 0 | 3.12% | 0.00% |
| April 8, 2024 | Taub Rebecca | Pres., R&D, and CMO | M | Stock Option (Right to Buy) | 2676 | $0.00 | 76,564.0000 | 0 | 3.38% | 0.00% |
| April 8, 2024 | Taub Rebecca | Pres., R&D, and CMO | S | Common Stock | 200 | $248.58 | 1,114,539.0000 | 0 | 0.02% | 0.00% |
| April 8, 2024 | Taub Rebecca | Pres., R&D, and CMO | S | Common Stock | 407 | $247.76 | 1,114,739.0000 | 0 | 0.04% | 0.00% |
| April 8, 2024 | Taub Rebecca | Pres., R&D, and CMO | S | Common Stock | 600 | $246.98 | 1,115,146.0000 | 0 | 0.05% | 0.00% |
| April 8, 2024 | Taub Rebecca | Pres., R&D, and CMO | S | Common Stock | 300 | $245.69 | 1,115,746.0000 | 0 | 0.03% | 0.00% |
| April 8, 2024 | Taub Rebecca | Pres., R&D, and CMO | S | Common Stock | 945 | $244.79 | 1,116,046.0000 | 0 | 0.08% | 0.00% |
| April 8, 2024 | Taub Rebecca | Pres., R&D, and CMO | S | Common Stock | 224 | $243.25 | 1,116,991.0000 | 0 | 0.02% | 0.00% |
| April 8, 2024 | Taub Rebecca | Pres., R&D, and CMO | M | Common Stock | 2676 | $9.45 | 1,117,215.0000 | 0 | 0.24% | 0.00% |
| April 8, 2024 | FRIEDMAN PAUL A | Not found | S | Common Stock | 3730 | $244.12 | 862,374.0000 | 0 | 0.43% | 0.00% |
| April 8, 2024 | FRIEDMAN PAUL A | Not found | S | Common Stock | 5663 | $244.86 | 856,711.0000 | 0 | 0.66% | 0.00% |
| April 8, 2024 | FRIEDMAN PAUL A | Not found | S | Common Stock | 2078 | $245.71 | 854,633.0000 | 0 | 0.24% | 0.00% |
| April 8, 2024 | FRIEDMAN PAUL A | Not found | S | Common Stock | 5028 | $246.96 | 849,605.0000 | 0 | 0.59% | 0.00% |
| April 8, 2024 | FRIEDMAN PAUL A | Not found | S | Common Stock | 3464 | $247.76 | 846,141.0000 | 0 | 0.41% | 0.00% |
| April 8, 2024 | FRIEDMAN PAUL A | Not found | S | Common Stock | 4866 | $248.59 | 841,275.0000 | 0 | 0.58% | 0.00% |
| April 8, 2024 | FRIEDMAN PAUL A | Not found | S | Common Stock | 1441 | $242.95 | 866,104.0000 | 0 | 0.17% | 0.00% |
| April 3, 2024 | Taub Rebecca | Pres., R&D, and CMO | S | Common Stock | 4070 | $244.68 | 1,135,545.0000 | 0 | 0.36% | 0.00% |
| April 5, 2024 | FRIEDMAN PAUL A | Director | M | Stock Option (Right to Buy) | 27613 | $0.00 | 232,526.0000 | 0 | 10.61% | 0.00% |
| April 4, 2024 | FRIEDMAN PAUL A | Director | M | Stock Option (Right to Buy) | 18710 | $0.00 | 260,139.0000 | 0 | 6.71% | 0.00% |
| April 3, 2024 | FRIEDMAN PAUL A | Director | M | Stock Option (Right to Buy) | 27407 | $0.00 | 278,849.0000 | 0 | 8.95% | 0.00% |
| April 5, 2024 | FRIEDMAN PAUL A | Director | S | Common Stock | 444 | $245.92 | 841,275.0000 | 0 | 0.05% | 0.00% |
| April 5, 2024 | FRIEDMAN PAUL A | Director | S | Common Stock | 5228 | $245.35 | 841,719.0000 | 0 | 0.62% | 0.00% |
| April 5, 2024 | FRIEDMAN PAUL A | Director | S | Common Stock | 3966 | $244.22 | 846,947.0000 | 0 | 0.47% | 0.00% |
| April 5, 2024 | FRIEDMAN PAUL A | Director | S | Common Stock | 9264 | $243.20 | 850,913.0000 | 0 | 1.08% | 0.00% |
| April 5, 2024 | FRIEDMAN PAUL A | Director | S | Common Stock | 6679 | $242.42 | 860,177.0000 | 0 | 0.77% | 0.00% |
| April 5, 2024 | FRIEDMAN PAUL A | Director | S | Common Stock | 612 | $241.15 | 866,856.0000 | 0 | 0.07% | 0.00% |
| April 5, 2024 | FRIEDMAN PAUL A | Director | S | Common Stock | 1420 | $240.10 | 867,468.0000 | 0 | 0.16% | 0.00% |
| April 5, 2024 | FRIEDMAN PAUL A | Director | M | Common Stock | 27613 | $9.45 | 868,888.0000 | 0 | 3.28% | 0.00% |
| April 4, 2024 | FRIEDMAN PAUL A | Director | S | Common Stock | 200 | $248.43 | 841,275.0000 | 0 | 0.02% | 0.00% |
| April 4, 2024 | FRIEDMAN PAUL A | Director | S | Common Stock | 737 | $247.14 | 841,475.0000 | 0 | 0.09% | 0.00% |
| April 4, 2024 | FRIEDMAN PAUL A | Director | S | Common Stock | 1558 | $246.13 | 842,212.0000 | 0 | 0.18% | 0.00% |
| April 4, 2024 | FRIEDMAN PAUL A | Director | S | Common Stock | 2549 | $245.14 | 843,770.0000 | 0 | 0.30% | 0.00% |
| April 4, 2024 | FRIEDMAN PAUL A | Director | S | Common Stock | 627 | $244.31 | 846,319.0000 | 0 | 0.07% | 0.00% |
| April 4, 2024 | FRIEDMAN PAUL A | Director | S | Common Stock | 1467 | $243.00 | 846,946.0000 | 0 | 0.17% | 0.00% |
| April 4, 2024 | FRIEDMAN PAUL A | Director | S | Common Stock | 5299 | $242.25 | 848,413.0000 | 0 | 0.62% | 0.00% |
| April 4, 2024 | FRIEDMAN PAUL A | Director | S | Common Stock | 6273 | $241.07 | 853,712.0000 | 0 | 0.73% | 0.00% |
| April 4, 2024 | FRIEDMAN PAUL A | Director | M | Common Stock | 18710 | $9.45 | 859,985.0000 | 0 | 2.22% | 0.00% |
| April 3, 2024 | FRIEDMAN PAUL A | Director | S | Common Stock | 1821 | $246.31 | 841,275.0000 | 0 | 0.22% | 0.00% |
| April 3, 2024 | FRIEDMAN PAUL A | Director | S | Common Stock | 18806 | $245.34 | 843,096.0000 | 0 | 2.18% | 0.00% |
| April 3, 2024 | FRIEDMAN PAUL A | Director | S | Common Stock | 4301 | $244.58 | 861,902.0000 | 0 | 0.50% | 0.00% |
| April 3, 2024 | FRIEDMAN PAUL A | Director | S | Common Stock | 2294 | $243.64 | 866,203.0000 | 0 | 0.26% | 0.00% |
| April 3, 2024 | FRIEDMAN PAUL A | Director | S | Common Stock | 185 | $242.00 | 868,497.0000 | 0 | 0.02% | 0.00% |
| April 3, 2024 | FRIEDMAN PAUL A | Director | M | Common Stock | 27407 | $9.45 | 868,682.0000 | 0 | 3.26% | 0.00% |
| April 5, 2024 | Taub Rebecca | Pres., R&D, and CMO | M | Stock Option (Right to Buy) | 27506 | $0.00 | 79,240.0000 | 0 | 25.77% | 0.00% |
| April 4, 2024 | Taub Rebecca | Pres., R&D, and CMO | M | Stock Option (Right to Buy) | 18537 | $0.00 | 106,746.0000 | 0 | 14.80% | 0.00% |
| April 3, 2024 | Taub Rebecca | Pres., R&D, and CMO | M | Stock Option (Right to Buy) | 27845 | $0.00 | 125,283.0000 | 0 | 18.18% | 0.00% |
| April 5, 2024 | Taub Rebecca | Pres., R&D, and CMO | S | Common Stock | 5278 | $245.53 | 1,114,539.0000 | 0 | 0.47% | 0.00% |
| April 5, 2024 | Taub Rebecca | Pres., R&D, and CMO | S | Common Stock | 2079 | $244.45 | 1,119,817.0000 | 0 | 0.19% | 0.00% |
| April 5, 2024 | Taub Rebecca | Pres., R&D, and CMO | S | Common Stock | 8989 | $243.33 | 1,121,896.0000 | 0 | 0.79% | 0.00% |
| April 5, 2024 | Taub Rebecca | Pres., R&D, and CMO | S | Common Stock | 8817 | $242.61 | 1,130,885.0000 | 0 | 0.77% | 0.00% |
| April 5, 2024 | Taub Rebecca | Pres., R&D, and CMO | S | Common Stock | 700 | $241.14 | 1,139,702.0000 | 0 | 0.06% | 0.00% |
| April 5, 2024 | Taub Rebecca | Pres., R&D, and CMO | S | Common Stock | 1643 | $240.11 | 1,140,402.0000 | 0 | 0.14% | 0.00% |
| April 5, 2024 | Taub Rebecca | Pres., R&D, and CMO | M | Common Stock | 27506 | $9.45 | 1,142,045.0000 | 0 | 2.47% | 0.00% |
| April 4, 2024 | Taub Rebecca | Pres., R&D, and CMO | S | Common Stock | 100 | $248.23 | 1,114,539.0000 | 0 | 0.01% | 0.00% |
| April 4, 2024 | Taub Rebecca | Pres., R&D, and CMO | S | Common Stock | 711 | $247.23 | 1,114,639.0000 | 0 | 0.06% | 0.00% |
| April 4, 2024 | Taub Rebecca | Pres., R&D, and CMO | S | Common Stock | 1653 | $246.01 | 1,115,350.0000 | 0 | 0.15% | 0.00% |
| April 4, 2024 | Taub Rebecca | Pres., R&D, and CMO | S | Common Stock | 2734 | $245.06 | 1,117,003.0000 | 0 | 0.24% | 0.00% |
| April 4, 2024 | Taub Rebecca | Pres., R&D, and CMO | S | Common Stock | 435 | $244.01 | 1,119,737.0000 | 0 | 0.04% | 0.00% |
| April 4, 2024 | Taub Rebecca | Pres., R&D, and CMO | S | Common Stock | 3085 | $242.71 | 1,120,172.0000 | 0 | 0.27% | 0.00% |
| April 4, 2024 | Taub Rebecca | Pres., R&D, and CMO | S | Common Stock | 5619 | $241.85 | 1,123,257.0000 | 0 | 0.50% | 0.00% |
| April 4, 2024 | Taub Rebecca | Pres., R&D, and CMO | S | Common Stock | 4200 | $240.88 | 1,128,876.0000 | 0 | 0.37% | 0.00% |
| April 4, 2024 | Taub Rebecca | Pres., R&D, and CMO | M | Common Stock | 18537 | $9.45 | 1,133,076.0000 | 0 | 1.66% | 0.00% |
| April 3, 2024 | Taub Rebecca | Pres., R&D, and CMO | S | Common Stock | 2089 | $246.32 | 1,114,539.0000 | 0 | 0.19% | 0.00% |
| April 3, 2024 | Taub Rebecca | Pres., R&D, and CMO | S | Common Stock | 18917 | $245.34 | 1,116,628.0000 | 0 | 1.67% | 0.00% |
| April 3, 2024 | Taub Rebecca | Pres., R&D, and CMO | S | Common Stock | 2634 | $243.68 | 1,139,615.0000 | 0 | 0.23% | 0.00% |
| April 3, 2024 | Taub Rebecca | Pres., R&D, and CMO | S | Common Stock | 135 | $242.00 | 1,142,249.0000 | 0 | 0.01% | 0.00% |
| April 3, 2024 | Taub Rebecca | Pres., R&D, and CMO | M | Common Stock | 27845 | $9.45 | 1,142,384.0000 | 0 | 2.50% | 0.00% |
| April 1, 2024 | BATE KENNETH | Director | S | Common Stock | 6698 | $255.62 | 15,777.0000 | 0 | 29.80% | 0.00% |
| April 1, 2024 | BATE KENNETH | Director | M | Common Stock | 10000 | $100.45 | 21,198.0000 | 0 | 89.30% | 0.00% |
| April 1, 2024 | BATE KENNETH | Director | M | Common Stock | 10000 | $9.45 | 11,198.0000 | 0 | 834.72% | 0.00% |
| April 1, 2024 | Levy Richard S | Not found | M | Stock Option (Right to Buy) | 6000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 1, 2024 | Levy Richard S | Not found | M | Stock Option (Right to Buy) | 5000 | $0.00 | 15,000.0000 | 0 | 25.00% | 0.00% |
| April 1, 2024 | Levy Richard S | Not found | S | Common Stock | 300 | $267.07 | 10,298.0000 | 0 | 2.83% | 0.00% |
| April 1, 2024 | Levy Richard S | Not found | S | Common Stock | 713 | $265.28 | 10,598.0000 | 0 | 6.30% | 0.00% |
| April 1, 2024 | Levy Richard S | Not found | S | Common Stock | 100 | $259.07 | 11,311.0000 | 0 | 0.88% | 0.00% |
| April 1, 2024 | Levy Richard S | Not found | S | Common Stock | 1600 | $257.93 | 11,411.0000 | 0 | 12.30% | 0.00% |
| April 1, 2024 | Levy Richard S | Not found | S | Common Stock | 3900 | $256.88 | 13,011.0000 | 0 | 23.06% | 0.00% |
| April 1, 2024 | Levy Richard S | Not found | S | Common Stock | 4387 | $255.90 | 16,911.0000 | 0 | 20.60% | 0.00% |
| April 1, 2024 | Levy Richard S | Not found | M | Common Stock | 6000 | $111.06 | 21,298.0000 | 0 | 39.22% | 0.00% |
| April 1, 2024 | Levy Richard S | Not found | M | Common Stock | 5000 | $7.36 | 15,298.0000 | 0 | 48.55% | 0.00% |
| April 1, 2024 | Daly James M | Director | S | Common Stock | 6809 | $255.64 | 15,966.0000 | 0 | 29.90% | 0.00% |
| April 1, 2024 | Daly James M | Director | M | Common Stock | 1577 | $105.08 | 22,775.0000 | 0 | 7.44% | 0.00% |
| April 1, 2024 | Daly James M | Director | M | Common Stock | 20000 | $100.45 | 21,198.0000 | 0 | 1669.45% | 0.00% |
| April 2, 2024 | BATE KENNETH | Director | M | Stock Option (Right to Buy) | 11212 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 1, 2024 | BATE KENNETH | Director | M | Stock Option (Right to Buy) | 1277 | $0.00 | 11,212.0000 | 0 | 10.23% | 0.00% |
| April 1, 2024 | BATE KENNETH | Director | M | Stock Option (Right to Buy) | 10000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 1, 2024 | BATE KENNETH | Director | M | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 0 | 50.00% | 0.00% |
| April 2, 2024 | BATE KENNETH | Director | S | Common Stock | 7 | $249.05 | 1,198.0000 | 0 | 0.58% | 0.00% |
| April 2, 2024 | BATE KENNETH | Director | S | Common Stock | 193 | $248.49 | 1,205.0000 | 0 | 13.81% | 0.00% |
| April 2, 2024 | BATE KENNETH | Director | S | Common Stock | 100 | $246.88 | 1,398.0000 | 0 | 6.68% | 0.00% |
| April 2, 2024 | BATE KENNETH | Director | S | Common Stock | 567 | $246.20 | 1,498.0000 | 0 | 27.46% | 0.00% |
| April 2, 2024 | BATE KENNETH | Director | S | Common Stock | 2080 | $244.97 | 2,065.0000 | 0 | 50.18% | 0.00% |
| April 2, 2024 | BATE KENNETH | Director | S | Common Stock | 7048 | $244.27 | 4,145.0000 | 0 | 62.97% | 0.00% |
| April 2, 2024 | BATE KENNETH | Director | S | Common Stock | 1217 | $243.28 | 11,193.0000 | 0 | 9.81% | 0.00% |
| April 2, 2024 | BATE KENNETH | Director | M | Common Stock | 11212 | $105.08 | 12,410.0000 | 0 | 935.89% | 0.00% |
| April 1, 2024 | BATE KENNETH | Director | S | Common Stock | 274 | $266.91 | 1,198.0000 | 0 | 18.61% | 0.00% |
| April 1, 2024 | BATE KENNETH | Director | S | Common Stock | 700 | $265.36 | 1,472.0000 | 0 | 32.23% | 0.00% |
| April 1, 2024 | BATE KENNETH | Director | S | Common Stock | 116 | $264.73 | 2,172.0000 | 0 | 5.07% | 0.00% |
| April 1, 2024 | BATE KENNETH | Director | S | Common Stock | 143 | $263.08 | 2,288.0000 | 0 | 5.88% | 0.00% |
| April 1, 2024 | BATE KENNETH | Director | S | Common Stock | 841 | $262.18 | 2,431.0000 | 0 | 25.70% | 0.00% |
| April 1, 2024 | BATE KENNETH | Director | S | Common Stock | 200 | $259.13 | 3,272.0000 | 0 | 5.76% | 0.00% |
| April 1, 2024 | BATE KENNETH | Director | S | Common Stock | 2104 | $258.24 | 3,472.0000 | 0 | 37.73% | 0.00% |
| April 1, 2024 | BATE KENNETH | Director | S | Common Stock | 2790 | $257.33 | 5,576.0000 | 0 | 33.35% | 0.00% |
| April 1, 2024 | BATE KENNETH | Director | S | Common Stock | 7411 | $256.49 | 8,366.0000 | 0 | 46.97% | 0.00% |
| April 1, 2024 | BATE KENNETH | Director | M | Common Stock | 1277 | $105.08 | 22,475.0000 | 0 | 6.02% | 0.00% |
| April 2, 2024 | Daly James M | Director | M | Stock Option (Right to Buy) | 10912 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 1, 2024 | Daly James M | Director | M | Stock Option (Right to Buy) | 1577 | $0.00 | 10,912.0000 | 0 | 12.63% | 0.00% |
| April 1, 2024 | Daly James M | Director | M | Stock Option (Right to Buy) | 20000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 2, 2024 | Daly James M | Director | S | Common Stock | 200 | $248.45 | 1,198.0000 | 0 | 14.31% | 0.00% |
| April 2, 2024 | Daly James M | Director | S | Common Stock | 43 | $247.03 | 1,398.0000 | 0 | 2.98% | 0.00% |
| April 2, 2024 | Daly James M | Director | S | Common Stock | 557 | $246.30 | 1,441.0000 | 0 | 27.88% | 0.00% |
| April 2, 2024 | Daly James M | Director | S | Common Stock | 2991 | $244.89 | 1,998.0000 | 0 | 59.95% | 0.00% |
| April 2, 2024 | Daly James M | Director | S | Common Stock | 6279 | $244.19 | 4,989.0000 | 0 | 55.72% | 0.00% |
| April 2, 2024 | Daly James M | Director | S | Common Stock | 842 | $243.26 | 11,268.0000 | 0 | 6.95% | 0.00% |
| April 2, 2024 | Daly James M | Director | M | Common Stock | 10912 | $105.08 | 12,110.0000 | 0 | 910.85% | 0.00% |
| April 1, 2024 | Daly James M | Director | S | Common Stock | 274 | $266.91 | 1,198.0000 | 0 | 18.61% | 0.00% |
| April 1, 2024 | Daly James M | Director | S | Common Stock | 500 | $265.49 | 1,472.0000 | 0 | 25.35% | 0.00% |
| April 1, 2024 | Daly James M | Director | S | Common Stock | 351 | $264.89 | 1,972.0000 | 0 | 15.11% | 0.00% |
| April 1, 2024 | Daly James M | Director | S | Common Stock | 178 | $263.31 | 2,323.0000 | 0 | 7.12% | 0.00% |
| April 1, 2024 | Daly James M | Director | S | Common Stock | 800 | $262.01 | 2,501.0000 | 0 | 24.24% | 0.00% |
| April 1, 2024 | Daly James M | Director | S | Common Stock | 200 | $259.11 | 3,301.0000 | 0 | 5.71% | 0.00% |
| April 1, 2024 | Daly James M | Director | S | Common Stock | 1460 | $258.28 | 3,501.0000 | 0 | 29.43% | 0.00% |
| April 1, 2024 | Daly James M | Director | S | Common Stock | 3604 | $257.30 | 4,961.0000 | 0 | 42.08% | 0.00% |
| April 1, 2024 | Daly James M | Director | S | Common Stock | 7401 | $256.50 | 8,565.0000 | 0 | 46.35% | 0.00% |
| March 21, 2024 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock Warrant (right to buy) | 970951 | $260.00 | 2,493,602.0000 | 0 | 63.77% | 0.00% |
| March 21, 2024 | BAKER BROS. ADVISORS LP | Not found | P | Common Stock Warrant (right to buy) | 86741 | $260.00 | 212,188.0000 | 0 | 69.15% | 0.00% |
| Jan. 23, 2024 | Lynch Brian Joseph | SVP and General Counsel | A | Stock Option (Right to Buy) | 5483 | $0.00 | 5,483.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2024 | Lynch Brian Joseph | SVP and General Counsel | A | Market Stock Unit | 3639 | $0.00 | 3,639.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2024 | Sibold William John | President and CEO | A | Common Stock | 12250 | $0.00 | 62,250.0000 | 0 | 24.50% | 0.00% |
| Jan. 23, 2024 | Sibold William John | President and CEO | A | Stock Option (Right to Buy) | 18459 | $0.00 | 18,459.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2024 | Sibold William John | President and CEO | A | Market Stock Unit | 12250 | $0.00 | 12,250.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2024 | Taub Rebecca | Pres., R&D, and CMO | A | Stock Option (Right to Buy) | 8718 | $0.00 | 8,718.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2024 | Howarth Alex G. | Chief Financial Officer | A | Market Stock Unit | 4803 | $0.00 | 4,803.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2024 | Lynch Brian Joseph | SVP and General Counsel | A | Common Stock | 3639 | $0.00 | 18,221.0000 | 0 | 24.96% | 0.00% |
| Jan. 23, 2024 | Howarth Alex G. | Chief Financial Officer | A | Stock Option (Right to Buy) | 7238 | $0.00 | 7,238.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2024 | Taub Rebecca | Pres., R&D, and CMO | A | Common Stock | 5786 | $0.00 | 1,114,539.0000 | 0 | 0.52% | 0.00% |
| Jan. 23, 2024 | Huntsman Carole | Chief Commercial Officer | A | Market Stock Unit | 3639 | $0.00 | 3,639.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2024 | Huntsman Carole | Chief Commercial Officer | A | Stock Option (Right to Buy) | 5483 | $0.00 | 5,483.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2024 | Huntsman Carole | Chief Commercial Officer | A | Common Stock | 3639 | $0.00 | 11,473.0000 | 0 | 46.45% | 0.00% |
| Jan. 23, 2024 | Taub Rebecca | Pres., R&D, and CMO | A | Market Stock Unit | 5786 | $0.00 | 5,786.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2024 | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | A | Common Stock | 1419 | $0.00 | 6,536.0000 | 0 | 27.73% | 0.00% |
| Jan. 23, 2024 | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | A | Stock Option (Right to Buy) | 2138 | $0.00 | 2,138.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2024 | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | A | Market Stock Unit | 1419 | $0.00 | 1,419.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2024 | Howarth Alex G. | Chief Financial Officer | A | Common Stock | 4803 | $0.00 | 18,737.0000 | 0 | 34.47% | 0.00% |
| Jan. 16, 2024 | Taub Rebecca | Pres., R&D, and CMO | F | Common Stock | 1546 | $243.92 | 1,108,753.0000 | 0 | 0.14% | 0.00% |
| Jan. 16, 2024 | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | F | Common Stock | 550 | $243.92 | 5,117.0000 | 0 | 9.71% | 0.00% |
| Jan. 16, 2024 | Howarth Alex G. | Chief Financial Officer | F | Common Stock | 1067 | $243.92 | 13,934.0000 | 0 | 7.11% | 0.00% |
| Jan. 16, 2023 | FRIEDMAN PAUL A | Not found | F | Common Stock | 2254 | $243.92 | 841,275.0000 | 0 | 0.27% | 0.00% |
| Jan. 16, 2024 | Lynch Brian Joseph | SVP and General Counsel | F | Common Stock | 949 | $243.92 | 14,582.0000 | 0 | 6.11% | 0.00% |